<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77340</article-id><article-id pub-id-type="doi">10.7554/eLife.77340</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Tumor elimination by clustered microRNAs miR-306 and miR-79 via noncanonical activation of JNK signaling</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-267888"><name><surname>Wang</surname><given-names>Zhaowei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4491-8502</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269151"><name><surname>Xia</surname><given-names>Xiaoling</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293879"><name><surname>Li</surname><given-names>Jiaqi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-198234"><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5839-9526</contrib-id><email>igaki.tatsushi.4s@kyoto-u.ac.jp</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0064kty71</institution-id><institution>State Key Laboratory of Biocontrol, School of Ecology, Sun Yat-sen University</institution></institution-wrap><addr-line><named-content content-type="city">Shenzhen</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kpeqv85</institution-id><institution>Laboratory of Genetics, Graduate School of Biostudies, Kyoto University, Yoshida-Konoe-cho</institution></institution-wrap><addr-line><named-content content-type="city">Kyoto</named-content></addr-line><country>Japan</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kq0pv72</institution-id><institution>Guangzhou Key Laboratory of Insect Development Regulation and Application Research, Institute of Insect Science and Technology &amp; School of Life Sciences, South China Normal University</institution></institution-wrap><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Banerjee</surname><given-names>Utpal</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e77340</elocation-id><history><date date-type="received" iso-8601-date="2022-01-25"><day>25</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-11"><day>11</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-02-11"><day>11</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.11.480121"/></event></pub-history><permissions><copyright-statement>© 2022, Wang et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Wang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77340-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-77340-figures-v2.pdf"/><abstract><p>JNK signaling plays a critical role in both tumor promotion and tumor suppression. Here, we identified clustered microRNAs (miRNAs) miR-306 and miR-79 as novel tumor-suppressor miRNAs that specifically eliminate JNK-activated tumors in <italic>Drosophila</italic>. While showing only a slight effect on normal tissue growth, miR-306 and miR-79 strongly suppressed growth of multiple tumor models, including malignant tumors caused by Ras activation and cell polarity defects. Mechanistically, these miRNAs commonly target the mRNA of an E3 ubiquitin ligase ring finger protein 146 (RNF146). We found that RNF146 promotes degradation of tankyrase (Tnks), an ADP-ribose polymerase that promotes JNK activation in a noncanonical manner. Thus, downregulation of RNF146 by miR-306 and miR-79 leads to hyper-enhancement of JNK activation. Our data show that, while JNK activity is essential for tumor growth, elevation of miR-306 or miR-79 overactivate JNK signaling to the lethal level via noncanonical JNK pathway and thus eliminate tumors, providing a new miRNA-based strategy against cancer.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tumor suppression</kwd><kwd>JNK signaling</kwd><kwd>cell death</kwd><kwd>microRNA</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>MEXT/JSPS KAKENHI</institution></institution-wrap></funding-source><award-id>20H05320</award-id><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>MEXT/JSPS KAKENHI</institution></institution-wrap></funding-source><award-id>21H05284</award-id><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>MEXT/JSPS KAKENHI</institution></institution-wrap></funding-source><award-id>21H05039</award-id><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>Project for Elucidating and Controlling Mechanisms of Aging and Longevity</award-id><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>20gm5010001</award-id><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012226</institution-id><institution>Fundamental Research Funds for the Central Universities</institution></institution-wrap></funding-source><award-id>Sun Yat-sen University</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Zhaowei</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012226</institution-id><institution>Fundamental Research Funds for the Central Universities</institution></institution-wrap></funding-source><award-id>22hytd05</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Zhaowei</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007428</institution-id><institution>Naito Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Igaki</surname><given-names>Tatsushi</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowships for Research in Japan</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Zhaowei</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><award-id>for Research in Japan</award-id><principal-award-recipient><name><surname>Xia</surname><given-names>Xiaoling</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>miR-306 and miR-79 selectively eliminate JNK-activated tumors, providing a new microRNA-based strategy against cancer.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cancer progression is driven by oncogenic alterations of intracellular signaling that lead to promotion of cell proliferation and suppression of cell death (<xref ref-type="bibr" rid="bib8">Croce, 2008</xref>). The c-Jun N-terminal kinase (JNK) pathway is an evolutionarily conserved mitogen-activated protein (MAP) kinase cascade that regulates both cell proliferation and cell death in normal development and cancer (<xref ref-type="bibr" rid="bib4">Bode and Dong, 2007</xref>; <xref ref-type="bibr" rid="bib11">Eferl and Wagner, 2003</xref>). Indeed, JNK signaling can act as both tumor promoter and tumor suppressor depending on the cellular contexts (<xref ref-type="bibr" rid="bib4">Bode and Dong, 2007</xref>; <xref ref-type="bibr" rid="bib6">Bubici and Papa, 2014</xref>; <xref ref-type="bibr" rid="bib25">Karin and Gallagher, 2005</xref>). Crucially, JNK signaling is often activated in various types of cancers (<xref ref-type="bibr" rid="bib6">Bubici and Papa, 2014</xref>; <xref ref-type="bibr" rid="bib44">Wu et al., 2019</xref>). Thus, accumulating evidence suggests that JNK signaling can be a critical therapeutic target for cancer. For instance, converting JNK’s role from pro-tumor to antitumor within tumor tissue could be an ideal anticancer strategy.</p><p><italic>Drosophila</italic> provides a superb model for studying the genetic pathway of cellular signaling and has made great contributions to understand the basic principle of tumor growth and progression (<xref ref-type="bibr" rid="bib13">Enomoto et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Tipping and Perrimon, 2014</xref>). The best-studied model of <italic>Drosophila</italic> malignant tumor is generated by clones of cells overexpressing oncogenic Ras (Ras<sup>V12</sup>) with simultaneous mutations in apicobasal polarity genes such as <italic>lethal giant larvae</italic> (<italic>lgl</italic>), <italic>scribble</italic> (<italic>scrib</italic>), or <italic>discs large</italic> (<italic>dlg</italic>) in the imaginal epithelium (<xref ref-type="bibr" rid="bib5">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib30">Pagliarini and Xu, 2003</xref>). These tumors activate JNK signaling and blocking JNK within the clones strongly suppresses their tumor growth (<xref ref-type="bibr" rid="bib20">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib37">Uhlirova and Bohmann, 2006</xref>), indicating that JNK acts as a pro-tumor signaling in these malignant tumors. Conversely, clones of cells overexpressing the oncogene Src in the imaginal discs activate JNK signaling and blocking JNK in these clones results in an enhanced overgrowth (<xref ref-type="bibr" rid="bib12">Enomoto and Igaki, 2013</xref>), indicating that JNK negatively regulates Src-induced tumor growth. Similarly, although clones of cells mutant for <italic>scrib</italic> or <italic>dlg</italic> in the imaginal discs are eliminated by apoptosis when surrounded by wild-type cells, blocking JNK in these clones suppresses elimination and causes tumorous overgrowth (<xref ref-type="bibr" rid="bib5">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib21">Igaki et al., 2009</xref>), indicating that JNK acts as antitumor signaling in these mutant clones. Thus, JNK also acts as both pro- and antitumor signaling depending on the cellular contexts in <italic>Drosophila</italic> imaginal epithelium.</p><p>miRNAs are a group of small noncoding RNAs that suppress target gene expression by mRNA degradation or translational repression and have been proposed to be potent targets for cancer therapy. Indeed, several cancer-targeted miRNA drugs have entered clinical trials in recent years. For instance, MRX34, a miRNA mimic drug developed from the tumor-suppressor miR-34a, is the first miRNA-based anticancer drug that has entered phase I clinical trials for patients with advanced solid tumors (<xref ref-type="bibr" rid="bib3">Beg et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Hong et al., 2020</xref>). In addition, MesomiR-1, a miR-16 mimic miRNA that targets EGFR, has entered phase I trial for the treatment of thoracic cancers (<xref ref-type="bibr" rid="bib31">Reid et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">van Zandwijk et al., 2017</xref>). Such miRNA-mediated anticancer strategy can be studied using the <italic>Drosophila</italic> tumor models. Indeed, in <italic>Drosophila</italic>, the conserved miRNA let-7 targets a transcription factor <italic>chinmo</italic> and thus suppresses tumor growth caused by <italic>polyhomeotic</italic> mutations (<xref ref-type="bibr" rid="bib23">Jiang et al., 2018</xref>). In addition, miR-8 acts as a tumor suppressor against Notch-induced <italic>Drosophila</italic> tumors by directly inhibiting the Notch ligand Serrate (<xref ref-type="bibr" rid="bib38">Vallejo et al., 2011</xref>). However, apart from these miRNAs that suppress growth of specific types of tumors, it is unclear whether there exist miRNAs that generally suppress tumor growth caused by different genetic alterations.</p><p>Here, using <italic>Drosophila</italic> tumor models and subsequent genetic analyses, we identified several tumor-suppressor miRNAs. Among these, miR-306 and miR-79, two clustered miRNAs located on the miR-9c/306/79/9b cluster, significantly suppressed growth of multiple types of JNK-activated tumors while showing only a slight effect on normal tissue growth. Mechanistically, miR-306 and miR-79 directly target <italic>RNF146</italic>, an E3 ubiquitin ligase that causes degradation of a JNK-promoting ADP-ribose polymerase Tnks, thereby overamplifying JNK signaling in tumors to the lethal levels via noncanonical JNK activation. Our findings provide a novel miRNA-based strategy that generally suppress growth of JNK-activating tumors.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of miR-306 and miR-79 as novel tumor-suppressor miRNAs</title><p>To identify novel antitumor miRNAs in <italic>Drosophila</italic>, we focused on 37 miRNA clusters or miRNAs that are highly expressed in <italic>Drosophila</italic> eye-antennal discs (<xref ref-type="bibr" rid="bib7">Chung et al., 2008</xref>). Using the Flippase (FLP)-Flp recognition target (FRT)-mediated genetic mosaic technique, each miRNA was overexpressed in clones of cells expressing Ras<sup>V12</sup> with simultaneous mutations in the apicobasal polarity gene <italic>dlg</italic> (Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic>) in the eye-antennal discs, the best-studied malignant tumor model in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib30">Pagliarini and Xu, 2003</xref>; <xref ref-type="fig" rid="fig1">Figure 1C</xref>; compare to <xref ref-type="fig" rid="fig1">Figure 1</xref>). We found that overexpression of miR-7, miR-79, miR-252, miR-276a, miR-276b, miR-282, miR-306, miR-310, miR-317, miR-981, miR-988, or the miR-9c/306/79/9b cluster in Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> clones dramatically suppressed tumor growth (<xref ref-type="fig" rid="fig1">Figure 1C–G</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D, R, S, T, W, Y, Z, AC, and AE</xref>, quantified in <xref ref-type="fig" rid="fig1">Figure 1H</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1AI</xref>). In addition, overexpression of miR-305, miR-995, or the miR-13a/13b-1/2c cluster mildly suppressed Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K, X and AF</xref>, quantified in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1AI</xref>). Clustered miRNAs are localized close to each other in the genome and are thus normally transcribed together, ensuring the transcription efficiency of miRNA genes (<xref ref-type="bibr" rid="bib24">Kabekkodu et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Ryazansky et al., 2011</xref>). Notably, overexpression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 dramatically inhibited Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth (<xref ref-type="fig" rid="fig1">Figure 1E–G</xref>, compare to <xref ref-type="fig" rid="fig1">Figure 1D</xref>, quantified in <xref ref-type="fig" rid="fig1">Figure 1H</xref>). In addition, overexpression of miR-306 or miR-79 was sufficient to rescue the reduced pupation rate and animal lethality caused by Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors in the eye-antennal discs (<xref ref-type="fig" rid="fig1">Figure 1I and L</xref>). A pervious study in <italic>Drosophila</italic> wing discs showed that overexpression of miR-79 suppressed tumor growth caused by coexpression of Ras<sup>V12</sup> and <italic>lgl</italic>-RNAi via unknown mechanisms (<xref ref-type="bibr" rid="bib33">Shu et al., 2017</xref>). Similarly, we found that overexpression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 strongly suppressed growth of Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumors in the eye-antennal discs (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A–D</xref>, quantified in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref>). Importantly, overexpression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 alone only slightly reduced clone size compared to wild-type (<xref ref-type="fig" rid="fig1">Figure 1M–P</xref>, quantified in <xref ref-type="fig" rid="fig1">Figure 1Q</xref>). These data indicate that miR-306 and miR-79 are tumor-suppressor miRNAs that only mildly suppress normal tissue growth but specifically block tumor growth in <italic>Drosophila</italic> imaginal epithelium.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>miR-306 and miR-79 suppress Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth.</title><p>(<bold>A–G</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>A</bold> and <bold>B</bold>, 5 days after egg laying, <bold>C–G</bold>, 7 days after egg laying). (<bold>H</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) in (<bold>A–G</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>I</bold>) Pupation rate of flies with indicated genotypes. Data from three independent experiment, n &gt; 30 for each group in one experiment; error bars, SD. (<bold>J</bold>) Eclosion rate of flies with indicated genotypes. Data from three independent experiment, n &gt; 30 for each group in one experiment; error bars, SD. (<bold>K, L</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>M–P</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>Q</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>M–P</bold>). Error bars, SD; **p&lt;0.01, ****,p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Effect of miRNAs or miRNA clusters on Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth.</title><p>(<bold>A–AH</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>AI</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–AH</bold>). The relative clone size of WT//Dlg<sup>-/-</sup>+Ras<sup>V12</sup>+Luc (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) is used as control in statistical analysis. The dashed horizontal line shows the relative clone size of WT//Dlg<sup>-/-</sup>+Ras<sup>V12</sup>+Luc on average (comes from the quantified data in <xref ref-type="fig" rid="fig1">Figure 1H</xref>). Error bars, SD; n.s., p&gt;0.05 (not significant), *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. N/A, no 7-day-old larva available.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig1-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>miR-306 and miR-79 suppress Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumor growth.</title><p>(<bold>A–D</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>E</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–D</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig1-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig1-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>miR-306 and miR-79 suppress tumor growth by promoting cell death</title><p>We next investigated the mechanism by which miR-306 and miR-79 suppress tumor growth. Immunostaining of Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> or Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumors with anti-cleaved DCP-1 antibody revealed that expression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 in tumor clones significantly increased the number of dying cells (<xref ref-type="fig" rid="fig2">Figure 2A–E</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–D</xref>, quantified in <xref ref-type="fig" rid="fig2">Figure 2F</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). In addition, blocking cell death in tumor clones by overexpressing the caspase inhibitor baculovirus p35 canceled the tumor-suppressive activity of miR-306 or miR-79, while p35 overexpression alone did not affect growth of normal tissues or Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors (<xref ref-type="fig" rid="fig2">Figure 2G–N</xref>, quantified in <xref ref-type="fig" rid="fig2">Figure 2O</xref>). These data indicate that the miR-9c/306/79/9b cluster, miR-306, or miR-79 suppresses tumor growth by inducing cell death. Importantly, overexpression of these miRNAs alone did not cause cell death in normal tissue (<xref ref-type="fig" rid="fig2">Figure 2P–S</xref>, quantified in <xref ref-type="fig" rid="fig2">Figure 2T</xref>), suggesting that miR-306 or miR-79 cooperates with a putative tumor-specific signaling activated in Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> or Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumors to induce synthetic lethality.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>miR-306 and mir-79 suppress Ras<sup>V12</sup><italic>/dlg<sup>-/-</sup></italic> tumor growth by inducing apoptosis.</title><p>(<bold>A–E</bold>) Eye-antennal disc bearing GFP-labeled clones (A’-E’) of indicated genotypes stained with anti-cleaved Dcp-1 antibody (A-E and A’-E’, <bold>A</bold>, 5 days after egg laying, <bold>B–E</bold>, 7 days after egg laying). (<bold>F</bold>) Quantification of dying cells in GFP-positive clone area in (<bold>A–E</bold>). Error bars, SD; **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>G–N</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>G</bold> and <bold>H</bold>, 5 days after egg laying, <bold>I–N</bold>, 7 days after egg laying). (<bold>O</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>G–N</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>P–S</bold>) Eye-antennal disc bearing GFP-labeled clones (<bold>P’-S’</bold>) of indicated genotypes stained with anti-cleaved Dcp-1 antibody (P-S and P’-S’, 5 days after egg laying). (<bold>T</bold>) Quantification of dying cells in GFP-positive clone area in (<bold>P–S</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant) by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig2-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig2-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>miR-306 and miR-79 induce apoptosis in Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumors.</title><p>(<bold>A–D</bold>) Eye-antennal disc bearing GFP-labeled clones (<bold>A’-D’</bold>) of indicated genotypes stained with anti-cleaved Dcp-1 antibody (A-D and A’-D’, 7 days after egg laying). (<bold>E</bold>) Quantification of dying cells in GFP-positive clone area in (<bold>A–D</bold>). Error bars, SD; **p&lt;0.01, ***p&lt;0.001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig2-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>miR-306 and miR-79 suppress tumor growth by enhancing JNK signaling</title><p>We thus examined whether Ras activation or cell polarity defect cooperates with miR-306 or miR-79 to induce cell death. Overexpression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 in Ras<sup>V12</sup>-expresing clones did not affect their growth (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–D</xref>, quantified in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>), indicating that Ras signaling does not cooperate with these miRNAs. Notably, overexpression of these miRNAs in <italic>dlg<sup>-/-</sup></italic> clones significantly reduced their clone size (<xref ref-type="fig" rid="fig3">Figure 3A–E</xref>, quantified in <xref ref-type="fig" rid="fig3">Figure 3F</xref>). In addition, blocking cell death by overexpression of p35 canceled the ability of these miRNAs to reduce <italic>dlg<sup>-/-</sup></italic> clone size (<xref ref-type="fig" rid="fig3">Figure 3G–O</xref>, quantified in <xref ref-type="fig" rid="fig3">Figure 3P</xref>), suggesting that these miRNAs block <italic>dlg<sup>-/-</sup></italic> clone growth by promoting cell death. These data show that miR-306 or miR-79 cooperates with loss of cell polarity to induce synthetic lethality.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>miR-306 and mir-79 suppress tumor growth and promote cell competition by promoting JNK signaling.</title><p>(<bold>A–E</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>F</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–E</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>G–O</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>P</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A, G–O</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>Q–W</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>Q</bold>, 5 days after egg laying, <bold>R–W</bold>, 7 days after egg laying). (<bold>X</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A, Q–W</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>Y–AA</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>AB</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>H, J, K, Y–AA</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig3-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplements 1</xref>–<xref ref-type="fig" rid="fig3s3">3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig3-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>miR-306 and miR-79 do not suppresses Ras<sup>V12</sup> tumor growth.</title><p>(<bold>A–D</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>E</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–D</bold>). Error bars, SD; n.s., p&gt;0.05 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig3-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>miR-306 and miR-79 promote JNK signaling in the eye-antennal disc and adult eye.</title><p>(<bold>A–C</bold>) Eye-antennal disc bearing GFP-labeled clones (A’-C’) of indicated genotypes stained with anti-phospho-JNK antibody (<bold>A-C, A’-C’</bold> and <bold>A’’-C’’</bold>, 5 days after egg laying). (<bold>D–F</bold>) Eye-antennal disc bearing GFP-labeled clones (<bold>D’-F’</bold>) of indicated genotypes in <italic>puc-lacZ</italic> background stained with anti-β-galactosidase antibody (<bold>D-F, D’-F’</bold> and <bold>D’’-F’’</bold>, 5 days after egg laying). (<bold>G</bold>) Lysates of adult head of indicated genotypes were subjected to Western blots using indicated antibodies. (<bold>H</bold>) Quantification of relative P-JNK signaling in (<bold>G</bold>) from three independent experiments. Error bars, SD; *, p&lt;0.05 by one-way ANOVA multiple-comparison test. (<bold>I–K</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>L</bold>) Quantification of adult eye size (normalized to control) of (<bold>I–K</bold>). Error bars, SD; n.s., p&gt;0.05 by one-way ANOVA multiple-comparison test. (<bold>M–O</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>P</bold>) Quantification of adult eye size (normalized to control) of (<bold>M–O</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Quantitative data or raw data for <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig3-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>miR-306 and miR-79 suppress Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumor growth by promoting JNK signaling.</title><p>(<bold>A–C</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>D</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of indicated genotypes. The quantified data in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2E</xref> are used as control (columns 1, 3, and 5). Error bars, SD; n.s., p&gt;0.05 (not significant), ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>E–J</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>K</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>E–J</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig3-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig3-figsupp3-v2.tif"/></fig></fig-group><p>We then sought to identify the polarity defect-induced intracellular signaling that cooperates with miR-306 or miR-79 to induce cell death. It has been shown that clones of cells mutant for cell polarity genes such as <italic>dlg</italic> activate JNK signaling via the <italic>Drosophila</italic> tumor necrosis factor (TNF) Eiger (<xref ref-type="bibr" rid="bib5">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib21">Igaki et al., 2009</xref>). We found that overexpression of miR-306 or miR-79 alone moderately activated JNK signaling in the eye-antennal discs, as visualized by anti-p-JNK antibody staining and the <italic>puc-LacZ</italic> reporter (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–F</xref>). In addition, Western blot analysis with anti-p-JNK antibody revealed that overexpression of miR-306 or miR-79 in the eyes using the GMR-Gal4 driver caused JNK activation (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2G</xref>, quantified in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2H</xref>). Notably, although overexpression of miR-306 or miR-79 alone in the eyes had no significant effect on eye morphology (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2I–K</xref>, quantified in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2L</xref>), they dramatically enhanced the reduced-eye phenotype caused by overexpression of Eiger (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2M–O</xref>, quantified in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2P</xref>). It has been shown that the severity of the reduced-eye phenotype depends on the levels of JNK activation and subsequent cell death (<xref ref-type="bibr" rid="bib19">Igaki et al., 2002</xref>; <xref ref-type="bibr" rid="bib20">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib21">Igaki et al., 2009</xref>), suggesting that miR-306 and miR-79 enhance Eiger-mediated activation of JNK signaling. Indeed, blocking JNK signaling by overexpression of a dominant-negative form of <italic>Drosophila</italic> JNK Basket (Bsk<sup>DN</sup>) canceled the tumor-suppressive activity of miR-306 or miR-79 against Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> or Ras<sup>V12</sup>/<italic>lgl<sup>-/-</sup></italic> tumors (<xref ref-type="fig" rid="fig3">Figure 3R–W</xref>, quantified in <xref ref-type="fig" rid="fig3">Figure 3X</xref>, and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A–C</xref>, quantified in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3D</xref>), while Bsk<sup>DN</sup> did not affect growth of normal tissues (<xref ref-type="fig" rid="fig3">Figure 3Q</xref> compare to <xref ref-type="fig" rid="fig3">Figure 3A</xref>, quantified in <xref ref-type="fig" rid="fig3">Figure 3X</xref>). Moreover, overexpression of Bsk<sup>DN</sup> significantly increased the size of <italic>dlg<sup>-/-</sup></italic> or <italic>lgl<sup>-/-</sup></italic> clones overexpressing miR-306 or miR-79 (<xref ref-type="fig" rid="fig3">Figure 3H, J, K, Y, Z, and AA</xref>, quantified in <xref ref-type="fig" rid="fig3">Figure 3AB</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E–J</xref>, quantified in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3K</xref>). Together, these data suggest that miR-306 and miR-79 suppress growth of malignant tumors by enhancing JNK signaling activation.</p></sec><sec id="s2-4"><title>miR-306 and miR-79 enhance JNK signaling stimulated by different upstream signaling</title><p>We next examined whether miR-306 or miR-79 suppresses growth of other types of tumors with elevated JNK signaling via an Eiger-independent mechanism. Overexpression of an activated form of the <italic>Drosophila</italic> PDGF/VEGF receptor homolog (PVR<sup>act</sup>) results in JNK activation and tumor formation in the wing disc (<xref ref-type="bibr" rid="bib40">Wang et al., 2016a</xref>) and eye-antennal disc (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, compare to <xref ref-type="fig" rid="fig4">Figure 4A</xref>, quantified in <xref ref-type="fig" rid="fig4">Figure 4F</xref>). This tumor growth was significantly suppressed by overexpression of the miR-9c/306/79/9b cluster, miR-306, or miR-79 (<xref ref-type="fig" rid="fig4">Figure 4B–E</xref>, quantified in <xref ref-type="fig" rid="fig4">Figure 4F</xref>). In addition, the size of clones overexpressing the oncogene Src64B in the eye-antennal disc (<xref ref-type="fig" rid="fig4">Figure 4H</xref>, compare to <xref ref-type="fig" rid="fig4">Figure 4G</xref>, quantified in <xref ref-type="fig" rid="fig4">Figure 4F</xref>), which activate JNK signaling (<xref ref-type="bibr" rid="bib12">Enomoto and Igaki, 2013</xref>), was significantly reduced when the miR-9c/306/79/9b cluster, miR-306, or miR-79 was coexpressed (<xref ref-type="fig" rid="fig4">Figure 4H–K</xref>, quantified in <xref ref-type="fig" rid="fig4">Figure 4L</xref>). Moreover, nonautonomous overgrowth of surrounding wild-type tissue by Src64B-overexpressing clones (<xref ref-type="bibr" rid="bib12">Enomoto and Igaki, 2013</xref>) was significantly suppressed by coexpression of these miRNAs (<xref ref-type="fig" rid="fig4">Figure 4M–P</xref>, quantified in <xref ref-type="fig" rid="fig4">Figure 4Q</xref>). Furthermore, the size of clones mutant for an RNA helicase Hel25E or an adaptor protein Mahj, both of which are eliminated by JNK-dependent cell competition when surrounded by wild-type cells (<xref ref-type="bibr" rid="bib29">Nagata et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Tamori et al., 2010</xref>), was significantly reduced when these miRNAs were coexpressed (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>, quantified in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>, and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F–I</xref>, quantified in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1J</xref>). In these tumors or cell competition models, ectopic expression of miR-306 or miR-79 enhanced JNK activity (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). We further examined whether expression of these miRNAs enhances normally occurring JNK activity during development. The pnr-GAL4 driver strain specifically expresses GAL4 in the wing discs in a broad domain corresponding to the central presumptive notum during metamorphosis (<xref ref-type="bibr" rid="bib22">Ishimaru et al., 2004</xref>; <xref ref-type="bibr" rid="bib47">Zeitlinger and Bohmann, 1999</xref>). Knocking down Hep, the <italic>Drosophila</italic> JNK kinase, using the pnr-GAL4 driver generates a split-thorax phenotype caused by reduced JNK signaling (<xref ref-type="bibr" rid="bib22">Ishimaru et al., 2004</xref>). On the contrary, ectopic expression of Hep or Eiger using pnr-GAL4 generates a small-scutellum phenotype caused by elevated JNK signaling (<xref ref-type="bibr" rid="bib28">Ma et al., 2013</xref>; <xref ref-type="bibr" rid="bib45">Xue et al., 2007</xref>). Similarly to Hep or Eiger, ectopic expression of miR-306 or miR-79 using pnr-GAL4 resulted in a small-scutellum phenotype (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A–C</xref>, quantified in <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3D</xref>). These data suggest that miR-306 and miR-79 broadly enhance JNK signaling activity stimulated by different upstream signaling.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>miR-306 and miR-79 suppress growth of multiple types of tumor models.</title><p>(<bold>A–E</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>A</bold>, 5 days after egg laying, <bold>B–E</bold>, 7 days after egg laying). (<bold>F</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–E</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>G–K</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>G</bold>, 5 days after egg laying, <bold>H–K</bold>, 6 days after egg laying). (<bold>L</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>G–K</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>M–P</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>Q</bold>) Quantification of percentage of folded eye in (<bold>M–P</bold>). n = 20 for each group.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref>–<xref ref-type="fig" rid="fig4s3">3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig4-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>miR-306 and miR-79 promote multiple types of cell competition.</title><p>(<bold>A–D</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>E</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A–D</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>F–I</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>J</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>F–I</bold>). Error bars, SD; ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig4-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>miR-306 and miR-79 enhance JNK signaling in multiple types of tumors or cell competition models.</title><p>(<bold>A–O</bold>) Eye-antennal disc bearing GFP-labeled clones (A’-O’) of indicated genotypes stained with anti-phospho-JNK antibody (A-O and A’-O’, <bold>A–F</bold>, 7 days after egg laying, <bold>G</bold>–<bold>I</bold>, 6 days after egg laying, <bold>J–O</bold>, 5 days after egg laying). (<bold>P</bold>) Quantification of the p-JNK signaling (% P-JNK-positive area in GFP-positive area) of (<bold>A–O</bold>). Error bars, SD; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig4-figsupp2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>miR-306 and miR-79 enhance normally occurring JNK activity.</title><p>(<bold>A–C</bold>) Adult scutellum phenotypes of flies with indicated genotypes. (<bold>D</bold>) Quantification of scutellum size of (<bold>A–C</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig4-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig4-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>miR-306 and miR-79 enhance JNK signaling activity by targeting RNF146</title><p>We next sought to identify the mechanism by which miR-306 and miR-79 enhance JNK signaling by searching for the target gene(s) of these miRNAs. The clustered miRNAs often target overlapping sets of genes and thus co-regulate various biological processes (<xref ref-type="bibr" rid="bib26">Kim et al., 2009</xref>; <xref ref-type="bibr" rid="bib41">Wang et al., 2016b</xref>; <xref ref-type="bibr" rid="bib46">Yuan et al., 2009</xref>). Given that miR-306 and miR-79 are located on the same miRNA cluster, we searched for the common targets of these miRNAs using the online software TargeyScanFly 7.2 (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org/fly_72/">http://www.targetscan.org/fly_72/</ext-link>) and found 11 mRNAs that were predicted to be targets of both miR-306 and miR-79 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We then examined whether knocking down of each one of these candidate genes could activate JNK signaling in <italic>Drosophila</italic> wing discs, where a clear JNK activation was observed when miR-306 or miR-79 was overexpressed (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). As a result, we found that knocking down of RNF146, but not any other available RNAis for the candidate genes, resulted in JNK activation (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). The RNF146 mRNA had putative target sites of miR-306 and miR-79 in its 3′UTR region (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). To confirm that RNF146 mRNA is a direct target of miR-306 and miR-79, we performed a dual-luciferase reporter assay in <italic>Drosophila</italic> S2 cells using wild-type RNF146 3′UTR (RNF146 WT) or mutant RNF146 3′UTR bearing mutations at the putative binding site of miR-306 (RNF146 m1) or miR-79 (RNF146 m2) (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). We found that miR-306 and miR-79 reduced wild-type RNF146 3′UTR expression but did not affect respective mutant RNF146 3′UTR (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), indicating that miR-306 and miR-79 directly target RNF146 3′UTR (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). We also confirmed that overexpression of miR-306 or miR-79 reduced the endogenous levels of RNF146 protein (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, quantified in <xref ref-type="fig" rid="fig5">Figure 5G</xref>) and that suppression of miR-306 and miR-79 functions by using miRNA sponges increased the endogenous levels of RNF146 protein in the adult eyes (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A</xref>, quantified in <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>miR-306 and mir-79 suppress tumor growth and promote cell competition by targeting RNF146.</title><p>Predicted targets of miR-306 and miR-79. (<bold>B, C</bold>) Wing disc of indicated genotypes with puc-lacZ background stained with anti-β-galactosidase antibody (<bold>B,C</bold> and <bold>B’, C’</bold>, 5 or 6 days after egg laying). (<bold>D</bold>) Schematic of the wild-type and mutation-type 3′UTR vector with miRNA binding sites for miR-306 and miR-79, respectively. Red letters shows the mutation sites. Red box shows the seed sequence pairing region. (<bold>E</bold>) RLU/FLU rate from dual-luciferase assay. n = 3, error bars, SD; n.s., p&gt;0.05 (not significant), **p&lt;0.01 by two-tailed Student’s <italic>t</italic>-test. (<bold>F</bold>) Lysates of adult heads of indicated genotypes were subjected to Western blots using indicated antibodies. (<bold>G</bold>) Quantification of relative levels of RNF146 protein in (<bold>F</bold>) from three independent experiments. Error bars, SD; *p&lt;0.05, **p&lt;0.01 by one-way ANOVA multiple-comparison test. (<bold>H–J</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>K</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>H–J</bold>). Error bars, SD; ****p&lt;0.0001 by two-tailed Student’s <italic>t</italic>-test. (<bold>L–M</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>N</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>L–M</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant) by two-tailed Student’s <italic>t</italic>-test. (<bold>O–R</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (7 days after egg laying). (<bold>S</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>O–R</bold>). Error bars, SD; *p&lt;0.05, **p&lt;0.01 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Quantitative data or raw data for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig5-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref>–<xref ref-type="fig" rid="fig5s6">6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig5-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>miR-306 and miR-79 promote JNK signaling in the wing disc.</title><p>(<bold>A–C</bold>) Wing disc of indicated genotypes stained with anti-phospho-JNK antibody (<bold>A-C</bold> and <bold>A’-C’</bold>, 5 or 6 days after egg laying). (<bold>D–F</bold>) Wing disc of indicated genotypes with puc-lacZ background stained with anti-β-galactosidase antibody (<bold>D-F</bold> and <bold>D’-F’</bold>, 5 or 6 days after egg laying).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>RNAis that target eight candidate genes do not induce JNK activation in the wing disc.</title><p>(<bold>A–H</bold>) Wing disc of indicated genotypes with puc-lacZ background stained with anti-β-galactosidase antibody (<bold>A-H</bold> and <bold>A’-H’</bold>, 5 or 6 days after egg laying).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Suppression of miR-306 and miR-79 functions promotes RNF146 protein level.</title><p>(<bold>A</bold>) Lysates of adult heads of indicated genotypes were subjected to Western blots using indicated antibodies. (<bold>B</bold>) Quantification of relative levels of RNF146 protein in (<bold>A</bold>) from three independent experiments. Error bars, SD; *p&lt;0.05 by two-tailed Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig5s3sdata1"><label>Figure 5—figure supplement 3—source data 1.</label><caption><title>Quantitative data or raw data for <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig5-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>miR-306 and miR-79 promote cell competition by targeting RNF146.</title><p>(<bold>A, B</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>C</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>A, B</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant) by two-tailed Student’s <italic>t</italic>-test. (<bold>D, E</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>F</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>D, E</bold>). Error bars, SD; ****p&lt;0.0001 by two-tailed Student’s <italic>t</italic>-test. (<bold>G–M</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes stained with anti-cleaved Dcp-1 antibody (5 days after egg laying). (<bold>N</bold>) Quantification of dying cells in GMR-Gal4 expressing area in (<bold>G–M</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>O–R</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>S</bold>) Quantification of adult eye size (normalized to control) of (<bold>O–R</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>T–W</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>X</bold>) Quantification of adult eye size (normalized to control) of (<bold>T–W</bold>). Error bars, SD; n.s., p&gt;0.05 (not significant), ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>Y–AB</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (5 days after egg laying). (<bold>AC</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>Y–AB</bold>). Error bars, SD; ***p&lt;0.001, ****p&lt;0.0001 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig5s4sdata1"><label>Figure 5—figure supplement 4—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig5-figsupp4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp4-v2.tif"/></fig><fig id="fig5s5" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 5.</label><caption><title>Knocking down of RNF146 promotes JNK phosphorylation in Ras<sup>V12</sup>/dlg<sup>-/-</sup> tumor.</title><p>(<bold>A, B</bold>) Eye-antennal disc bearing GFP-labeled clones (<bold>A’, B’</bold>) of indicated genotypes (<bold>A, B</bold> and <bold>A’, B’</bold>, 7 days after egg laying). (<bold>C</bold>) Quantification of P-JNK signaling (% P-JNK-positive area in GFP-positive area) of (<bold>A, B</bold>). Error bars, SD; *p&lt;0.05 by two-tailed Student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig5s5sdata1"><label>Figure 5—figure supplement 5—source data 1.</label><caption><title>Quantitative data for <xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig5-figsupp5-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp5-v2.tif"/></fig><fig id="fig5s6" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 6.</label><caption><title>miR-9 is predicted to target mammalian RNF146.</title><p>Schematic of the miRNA binding sites for miR-9. Red box shows the seed sequence pairing region.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig5-figsupp6-v2.tif"/></fig></fig-group><p>We next investigated whether RNF146 is the responsible target of miR-306 and miR-79 for the enhancement of JNK signaling. We found that, while knockdown of RNF146 did not affect normal tissue growth (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4A and B</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4C</xref>), it significantly suppressed Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth (<xref ref-type="fig" rid="fig5">Figure 5H–J</xref>, quantified in <xref ref-type="fig" rid="fig5">Figure 5K</xref>) and promoted elimination of <italic>dlg<sup>-/-</sup></italic> clones (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4D and E</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4F</xref>). Although overexpression of one copy of miR-306 or miR-79 in the eyes had no significant effect on the number of dying cells or eye morphology (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2I–K</xref>, quantified in <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2L</xref>, <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4G–J</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4N</xref>), overexpression of 2×miR-306 or 2×miR-79 in the eyes significantly increased the number of dying cells (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4K–M</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4N</xref>) and resulted in a reduced-eye phenotype (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4O and Q</xref>). Overexpression of RNF146 rescued the reduced-eye phenotype caused by overexpression of 2×miR-306 or 2×miR-79 in the eyes (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4O–R</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4S</xref>). Moreover, knocking down of RNF146 significantly enhanced Eiger-induced reduced-eye phenotype (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4T–W</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4X</xref>). Furthermore, although overexpression of RNF146 did not affect Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumor growth (<xref ref-type="fig" rid="fig5">Figure 5L–M</xref>, quantified in <xref ref-type="fig" rid="fig5">Figure 5N</xref>), overexpression of RNF146 weakened the tumor-suppressive effect of miR-306 or miR-79 on Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors (<xref ref-type="fig" rid="fig5">Figure 5O–R</xref>, quantified in <xref ref-type="fig" rid="fig5">Figure 5S</xref>). The RNF146 overexpression also weakened the enhanced elimination of <italic>dlg<sup>-/-</sup></italic> clones by miR-306 or miR-79 (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4Y–AB</xref>, quantified in <xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4AC</xref>). Similarly to ectopic expression of miR-306 or miR-79, knocking down of RNF146 enhanced JNK activity in Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5A and B</xref>, quantified in <xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5C</xref>). Together, these data indicate that miR-306 and miR-79 directly target RNF146 mRNA, thereby enhancing JNK signaling activity and thus exerting the tumor-suppressive effects.</p></sec><sec id="s2-6"><title>RNF146 promotes Tnks degradation</title><p>We next investigated the mechanism by which downregulation of RNF146 by miR-306 or miR-79 enhances JNK signaling activity. It has been shown in <italic>Drosophila</italic> embryos, larvae, wing discs, and adult eyes that loss of RNF146 upregulates the protein levels of Tnks (<xref ref-type="bibr" rid="bib16">Gultekin and Steller, 2019</xref>; <xref ref-type="bibr" rid="bib42">Wang et al., 2019</xref>), a poly-ADP-ribose polymerase that directly mediates poly-ADP ribosylation of JNK, which triggers K63-linked poly-ubiquitination of JNK and thereby promotes JNK-dependent apoptosis in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib14">Feng et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Li et al., 2018</xref>). In addition, loss of RNF146 was shown to enhance rough-eye phenotype caused by Tnks overexpression (<xref ref-type="bibr" rid="bib16">Gultekin and Steller, 2019</xref>). These observations raise the possibility that downregulation of RNF146 by miR-306 or miR-79 enhances JNK signaling via upregulation of Tnks. Indeed, as reported previously (<xref ref-type="bibr" rid="bib14">Feng et al., 2018</xref>; <xref ref-type="bibr" rid="bib27">Li et al., 2018</xref>), Western blot analysis revealed that overexpression of Tnks induces phosphorylation of JNK (JNK activation) in S2 cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, lane 2 vs. lane 1, quantified in <xref ref-type="fig" rid="fig6">Figure 6C</xref>). Notably, coexpression of RNF146 significantly downregulated Tnks protein level and suppressed Tnks-induced JNK phosphorylation (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, lane 3 vs. lane 2, quantified in <xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). Moreover, knocking down of RNF146 or overexpression of miR-306 or miR-79 significantly upregulated Tnks protein level and promoted JNK phosphorylation (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, quantified in <xref ref-type="fig" rid="fig6">Figure 6E and F</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>, quantified in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B and C</xref>). These data support the notion that downregulation of RNF146 or overexpression of miR-306 or miR-79 enhances JNK activation via upregulation of Tnks. Indeed, overexpression of Tnks was sufficient to suppress growth of either normal tissues or Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors (<xref ref-type="fig" rid="fig6">Figure 6G–J</xref>, quantified in <xref ref-type="fig" rid="fig6">Figure 6K</xref>). Due to the fact that overexpression of Tnks alone resulted in larger clone size than Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic>+Tnks clone (<xref ref-type="fig" rid="fig6">Figure 6H and J</xref>, quantified in <xref ref-type="fig" rid="fig6">Figure 6K</xref>), our data support the notion that Tnks suppresses growth of Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors by cooperating with JNK signaling. Consistent with the data shown above, overexpression of Tnks rescued the lethality of flies bearing Ras<sup>V12</sup>/<italic>dlg<sup>-/-</sup></italic> tumors in the eye-antennal discs (<xref ref-type="fig" rid="fig6">Figure 6L and M</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>RNF146 promotes poly-ubiquitination and degradation of Tnks.</title><p>(<bold>A</bold>) <italic>Drosophila</italic> S2 cells were transfected with plasmids expressing indicated proteins. Cell lysates were subjected to Western blots using indicated antibodies. (<bold>B</bold>) Quantification of relative Tnks-myc levels in (<bold>A</bold>) from three independent experiments. Error bars, SD; ***p&lt;0.001 by two-tailed Student’s <italic>t</italic>-test. (<bold>C</bold>) Quantification of relative p-JNK levels in (<bold>A</bold>) from three independent experiments. Error bars, SD; *p&lt;0.05 by one-way ANOVA multiple-comparison test. (<bold>D</bold>) <italic>Drosophila</italic> S2 cells were transfected with plasmid expressing indicated protein and dsRNA targeting indicated gene. (<bold>E, F</bold>) Quantification of relative Tnks-myc levels (<bold>E</bold>) and p-JNK (<bold>F</bold>) levels in (<bold>D</bold>) from three independent experiments. Error bars, SD; *p&lt;0.05, ***p&lt;0.001 by one-way ANOVA multiple-comparison test. (<bold>G–J</bold>) Eye-antennal disc bearing GFP-labeled clones of indicated genotypes (<bold>G, H</bold>, 5 days after egg laying, <bold>I, J</bold>, 7 days after egg laying). (<bold>K</bold>) Quantification of clone size (% of total clone area per disc area in eye-antennal disc) of (<bold>G–J</bold>). Error bars, SD; ****p&lt;0.0001 by one-way ANOVA multiple-comparison test. (<bold>L</bold>) Adult eye phenotype of flies with indicated genotypes. (<bold>M</bold>) Eclosion rate of flies with indicated genotypes. Data from three independent experiment, n &gt; 30 for each group in one experiment; error bars, SD. (<bold>N, O</bold>) <italic>Drosophila</italic> S2 cells were transfected with plasmid expressing indicated protein and dsRNA targeting indicated gene. After 36 hr, cells were treated with 50 μg/ml cycloheximide (CHX) for the indicated periods. Cell lysates were subjected to Western blots using indicated antibodies. (<bold>P</bold>) Quantification of relative Tnks-myc levels in (<bold>N, O</bold>) from three independent experiments. Error bars, SD. (<bold>Q</bold>) A model for tumor elimination by miR-306/79. Tumor cell with elevated canonical JNK signaling via Eiger/TNF, dTAK1/JNKKK, and Hep/JNKK grows in a Bsk/JNK-dependent manner. Overexpression of miR-306 or miR-79 in JNK-activated tumor cell results in overactivation of JNK signaling to the lethal level via RNF146-Tnks-mediated noncanonical JNK-activating signaling. Overexpression of miR-306 or miR-79 in normal cells has no significant effect on JNK signaling.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Quantitative data or raw data for <xref ref-type="fig" rid="fig6">Figure 6</xref> (part 1).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig6-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Quantitative data or raw data for <xref ref-type="fig" rid="fig6">Figure 6</xref> (part 2).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig6-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Genotypes for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig6-data3-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>miR-306 and miR-79 increase Tnks protein level.</title><p>(<bold>A</bold>) <italic>Drosophila</italic> S2 cells were transfected with plasmids expressing indicated protein and miRNAs. Cell lysates were subjected to Western blots using indicated antibodies. (<bold>B, C</bold>) Quantification of relative levels of Tnks-myc (<bold>B</bold>) and p-JNK (<bold>C</bold>) in (<bold>A</bold>) from three independent experiments. Error bars, SD; *p&lt;0.05, **p&lt;0.01 by one-way ANOVA multiple-comparison test.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77340-fig6-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77340-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Finally, we sought to clarify the mechanism by which downregulation of RNF146 upregulates Tnks. A pervious study has shown that Tnks protein levels were significantly higher in <italic>Rnf146</italic> mutant background than in wild-type (<xref ref-type="bibr" rid="bib16">Gultekin and Steller, 2019</xref>). However, this upregulation of Tnks can be caused by either elevated Tnks protein synthesis or reduced Tnks protein degradation. We thus examined the possibility that RNF146 promotes degradation of Tnks. Blocking new protein synthesis in S2 cells by the protein synthesis inhibitor cycloheximide (CHX) resulted in a time-dependent depletion of Tnks protein with a half-life of less than 3 hr (<xref ref-type="fig" rid="fig6">Figure 6N</xref>, quantified in <xref ref-type="fig" rid="fig6">Figure 6P</xref>). This depletion of Tnks was significantly retarded when RNF146 was knocked down (<xref ref-type="fig" rid="fig6">Figure 6O</xref>, quantified in <xref ref-type="fig" rid="fig6">Figure 6P</xref>). These data indicate that endogenous RNF146 promotes degradation of Tnks protein. Taken together, our data show that miR-306 or miR-79 directly targets RNF146, thereby leading to elevation of Tnks protein that induces noncanonical activation of JNK signaling (<xref ref-type="fig" rid="fig6">Figure 6Q</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we have identified the clustered miRNAs miR-306 and miR-79 as novel antitumor miRNAs that selectively eliminate JNK-activated tumors from <italic>Drosophila</italic> imaginal epithelia. Mechanistically, miR-306 and miR-79 directly target RNF146, an E3 ligase that promotes degradation of a poly-ADP-ribose polymerase Tnks, thereby leading to upregulation of Tnks and thus promoting JNK activation (<xref ref-type="fig" rid="fig6">Figure 6K</xref>). Importantly, this noncanonical mode of JNK activation has only a weak effect on normal tissue growth but it strongly blocks tumor growth by overactivating JNK signaling when tumors already possess elevated JNK signaling via the canonical JNK pathway (<xref ref-type="fig" rid="fig6">Figure 6K</xref>). Given that tumors or premalignant mutant cells often activate canonical JNK signaling, miR-306 and miR-79 can be novel ideal targets of cancer therapy.</p><p>Our study identified several putative co-target genes of miR-306 and miR-79 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Interestingly, some of these genes (<italic>Atf3</italic>, <italic>chinmo</italic>, and <italic>chn</italic>) have been reported to be involved in tumor growth in <italic>Drosophila. Atf3</italic> encodes an AP-1 transcription factor that was shown to be a polarity-loss responsive gene acting downstream of the membrane-associated Scrib polarity complex (<xref ref-type="bibr" rid="bib10">Donohoe et al., 2018</xref>). Knockdown of <italic>Atf3</italic> suppresses growth and invasion of Ras<sup>V12</sup>/<italic>scrib<sup>-/-</sup></italic> tumors in eye-antennal discs (<xref ref-type="bibr" rid="bib2">Atkins et al., 2016</xref>). <italic>Chinmo</italic> is a BTB-zinc finger oncogene that is upregulated by JNK signaling in tumors (<xref ref-type="bibr" rid="bib9">Doggett et al., 2015</xref>). Although loss of <italic>chinmo</italic> does not significantly suppress tumor growth, overexpression of <italic>chinmo</italic> with Ras<sup>V12</sup> or an activated Notch is sufficient to promote tumor growth in eye-antennal discs (<xref ref-type="bibr" rid="bib9">Doggett et al., 2015</xref>). <italic>Chn</italic> encodes a zinc finger transcription factor that cooperates with <italic>scrib<sup>-/-</sup></italic> to promote tumor growth (<xref ref-type="bibr" rid="bib36">Turkel et al., 2013</xref>). Although we found that knockdown of these genes did not activate JNK signaling, it is possible that these putative target genes also contribute to the miR-306/miR-79-induced tumor suppression.</p><p>Intriguingly, it has been reported that miR-79 is downregulated in Ras<sup>V12</sup>/<italic>lgl-RNAi</italic> tumors in <italic>Drosophila</italic> wing discs (<xref ref-type="bibr" rid="bib33">Shu et al., 2017</xref>). Given that miR-306 is located in the same miRNA cluster with miR-79, it is highly possible that miR-306 is also downregulated in tumors. This suggests that tumors have the mechanism that downregulates antitumor miRNAs for their survival and growth. Future studies on the mechanism of how tumors regulate these miRNAs would provide new understanding of tumor biology.</p><p>Our study uncovered the miR-306/79-RNF146-Tnks axis as noncanonical JNK enhancer that selectively eliminates JNK-activated tumors in <italic>Drosophila</italic>. Considering that miR-9, the mammalian homolog of miR-79, is predicted to target mammalian RNF146 (<xref ref-type="fig" rid="fig5s6">Figure 5—figure supplement 6</xref>) and that JNK signaling is highly conserved throughout evolution, it opens up the possibility of developing a new miRNA-based strategy against cancer.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Fly stocks</title><p>All flies used were reared at 25°C on a standard cornmeal/yeast diet. Fluorescently labeled mitotic clones were produced in larval imaginal discs using the following strains: Tub-Gal80, FRT40A; eyFLP6, Act&gt;y<sup>+</sup>&gt;Gal4, UAS-GFP (40A tester), FRT42D, Tub-Gal80/CyO; eyFLP6, Act&gt;y<sup>+</sup>&gt;Gal4, UAS-GFP (42D tester), Tub-Gal80, FRT19A; eyFLP5, Act&gt;y<sup>+</sup>&gt;Gal4, UAS-GFP (19A tester #1), Tub-Gal80, FRT19A; eyFLP6, Act&gt;y<sup>+</sup>&gt;Gal4, UAS-GFP (19A tester #2). Additional strains used are the following: dlg<sup>m52</sup> (<xref ref-type="bibr" rid="bib15">Goode and Perrimon, 1997</xref>), puc-lacZ (<xref ref-type="bibr" rid="bib20">Igaki et al., 2006</xref>), UAS-Ras<sup>v12</sup> (<xref ref-type="bibr" rid="bib20">Igaki et al., 2006</xref>), UAS-Bsk<sup>DN</sup> (<xref ref-type="bibr" rid="bib1">Adachi-Yamada et al., 1999</xref>), UAS-Src64B (<xref ref-type="bibr" rid="bib43">Wills et al., 1999</xref>), Hel25E<sup>ccp-8</sup> (<xref ref-type="bibr" rid="bib29">Nagata et al., 2019</xref>), Mahj<sup>1</sup> (<xref ref-type="bibr" rid="bib34">Tamori et al., 2010</xref>), UAS-N<sup>act</sup> (<xref ref-type="bibr" rid="bib18">Hori et al., 2004</xref>), UAS-RNF146 (<xref ref-type="bibr" rid="bib16">Gultekin and Steller, 2019</xref>); lgl<sup>4</sup> (BDSC #36289), UAS-p35 (BDSC #5073), UAS-PVR<sup>act</sup> (BDSC #58496), UAS-Yki<sup>S168A</sup> (BDSC #28836), UAS-Luciferase (BDSC #35788), UAS-RFP (BDSC #30556), UAS-bantam (BDSC #60672), UAS-miR-9c,306,79,9b (BDSC #41156), UAS-miR-79 (BDSC #41145), UAS-miR-2a-2,2a-1,2b-2 (BDSC #59849), UAS-miR-2b-1 (BDSC #41128), UAS-miR-7 (BDSC #41137), UAS-miR-8 (BDSC #41176), UAS-miR-9a (BDSC #41138), UAS-miR-9b (BDSC #41131), UAS-miR-9c (BDSC #41139), UAS-miR-11 (BDSC #59865), UAS-miR-12 (BDSC #41140), UAS-miR-13a,13b-1,2c (BDSC #64097), UAS-miR-13b-2 (BDSC #59867), UAS-miR-14 (BDSC #41178), UAS-miR-34 (BDSC #41158), UAS-miR-92a (BDSC #41153), UAS-miR-124 (BDSC #41126), UAS-miR-184 (BDSC #41174), UAS-miR-252 (BDSC #41127), UAS-miR-276a (BDSC #41143), UAS-miR-276b (BDSC #41162), UAS-miR-278 (BDSC #41180), UAS-miR-279 (BDSC #41147), UAS-miR-282 (BDSC #41165), UAS-miR-305 (BDSC #41152), UAS-miR-310 (BDSC #41155), UAS-miR-317 (BDSC #59913), UAS-miR-958 (BDSC #41222), UAS-miR-975,976,977 (BDSC #60635), UAS-miR-981 (BDSC #60639), UAS-miR-984 (BDSC #41224), UAS-miR-988 (BDSC #41196), UAS-miR-995 (BDSC #41199), UAS-miR-996 (BDSC #60653), UAS-miR-998 (BDSC #63043), UAS-miR-306-sponge (BDSC #61424), UAS-miR-79-sponge (BDSC #61387), UAS-Luciferase RNAi (BDSC #31603), UAS-aop RNAi (BDSC #34909), UAS-pde1c RNAi (BDSC #55925), UAS-atf3 RNAi (BDSC #26741), UAS-mei-P26 RNAi (BDSC #57268), UAS-chn RNAi (BDSC #26779), UAS-chinmo RNAi (BDSC #26777), UAS-RNF146 RNAi (BDSC #40882), UAS-bcd RNAi (BDSC #33886) and UAS-CG1358 RNAi (BDSC #64848) from Bloomington <italic>Drosophila</italic> Stock Center; UAS-miR-306 (FlyORF #F002214) from FlyORF; UAS-Tnks from Core Facility of <italic>Drosophila</italic> Resource and Technology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences.</p></sec><sec id="s4-2"><title>Clone size measurement</title><p>Eye-antennal disc images were taken with a Leica SP8 confocal microscope or Olympus Fluoview FV3000 confocal microscope. To measure clone size, ImageJ (Fiji) software was used to determine the threshold of the fluorescence. Total clone area/disc area (%) in the eye-antennal disc was calculated using ImageJ and Prism 8 (GraphPad).</p></sec><sec id="s4-3"><title>Histology</title><p>Larval tissues were stained with standard immunohistochemical procedures using rabbit anti-phospho-JNK polyclonal antibody (Cell Signaling Technology, Cat #4668, 1:100), chicken anti-β-galactosidase antibody (Abcam, Cat #ab9361, 1:1000), rabbit anti-Cleaved <italic>Drosophila</italic> Dcp-1 (Asp216) antibody (Cell Signaling Technology, Cat #9578, 1:100), goat anti-rabbit secondary antibody, Alexa Fluor 647 (Thermo Fisher Scientific, Cat #A32733, 1:250) or goat anti-chicken secondary antibody, Alexa Fluor 647 (Thermo Fisher Scientific, Cat #A21449, 1:250). Samples were mounted with DAPI-containing SlowFade Gold Antifade Reagent (Thermo Fisher Scientific, Cat #S36937). Images were taken with a Leica SP8 confocal microscope. The cleaved Dcp-1 positive cell number and the P-JNK-positive area was calculated using ImageJ and Prism 8 (GraphPad).</p></sec><sec id="s4-4"><title>Plasmid and in vitro transcription of dsRNA</title><p>pAc5.1/V5-His vector (Thermo Fisher Scientific, Cat #V411020) was used to construct plasmids for expressing proteins or miRNAs in <italic>Drosophila</italic> S2 cells. The RNF146 or Tnks ORF was amplified from fly cDNAs via PCR. The RNF146 ORF was cloned into the EcoR І-Xho І site of the pAc5.1/V5-His vector. The Tnks ORF carrying a myc tag at its 5′-end was cloned into the Kpn І-Xho І site of the pAc5.1/V5-His vector. Extended region of miR-306 (–184 to +136) or miR-79 (–124 to +131) was amplified from fly cDNAs via PCR and cloned into the Kpn І-EcoR І site of the pAc5.1/V5-His vector.</p><p>RNF146 dsRNA #1 and #2, respectively, targeting the 1–318 and 319–667 region of RNF146 ORF, used for RNF146 RNAi were transcribed in vitro using T7 RNA polymerase (Promega, Cat #P2075) at 37°C for 4 hr from the PCR products.</p></sec><sec id="s4-5"><title>Cell culture and transfection</title><p><italic>Drosophila</italic> S2-ATCC cells (RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_Z232">:CVCL_Z232</ext-link>) was obtained from American Type Culture Collection (ATCC). Its identity was confirmed by visual inspection of the cell morphology and its growth kinetics in Schneider’s <italic>Drosophila</italic> medium (Thermo Fisher Scientific, Cat #21720024)/10% fetal bovine serum (FBS) and penicillin/streptomycin. A mycoplasma test is usually not done for S2 cells.</p><p>For transfection assay, S2 cells were plated in 100 mm plates or six-well plates and grown overnight to reach 70% confluence. After that, DNA plasmids or dsRNAs were transfected into the cells using FuGene HD transfection reagent (Promega, Cat #PRE2311) according to the manufacturer’s protocol. The protein synthesis inhibitor CHX (Santa Cruz Biotechnology, Cat #SC-3508) was used at 50 μg/ml.</p></sec><sec id="s4-6"><title>Western blots</title><p>Cultured <italic>Drosophila</italic> S2 cells were harvested and then lysed in cell lysis buffer. The cell lysates were then subjected to SDS-PAGE, followed by Western blots using anti-α-tubulin monoclonal antibody (Sigma-Aldrich, Cat #T5168, 1:5000), anti-phospho-JNK polyclonal antibody (Cell Signaling Technology, Cat #9251, 1:1000), anti-JNK monoclonal antibody (Santa Cruz Biotechnology, Cat #sc-7345, 1:1000), anti-RNF146 polyclonal antibody (raised in rabbits against the peptide HSGGGSGEDPAVGSC, GenScript antibody service, Nanjing, China, 1:2000), anti-V5 tag monoclonal antibody (Thermo Fisher Scientific, Cat #R960-25, 1:5000), anti-myc tag polyclonal antibody (MBL, Code #562, 1:1000), anti-mouse IgG, HRP-linked antibody (Cell Signaling Technology, Cat #7076, 1:5000), or anti-rabbit IgG, HRP-linked antibody (Cell Signaling Technology, Cat #7074, 1:5000).</p></sec><sec id="s4-7"><title>Dual-luciferase reporter assay</title><p>The psiCHECK-2 vector (Promega, Cat #C8021) was used to construct plasmids for dual-luciferase reporter assay. RNF146 3′UTR or its mutant was cloned into the Xho І-Not I site of the psiCHECK-2 vector. Renilla luciferase activity and firefly luciferase activity were measured using GloMax-Multi Jr Single-Tube Multimode Reader (Promega) according to the manufacturer’s protocol.</p></sec><sec id="s4-8"><title>Statistical analysis</title><p>When comparing two groups, statistical significance was tested using a Student’s <italic>t</italic>-test. When comparing multiple groups, statistical significance was tested using a one-way ANOVA multiple-comparison test. In all figures, significance is indicated as follows: n.s. (not significant), p&gt;0.05, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Visualization, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-77340-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All relevant data are within the paper and its Supporting Information files. All the numerical data that are represented as a graph in a figure are provided in the Source Data file.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank M Matsuoka and K Gomi for technical support, Hermann Steller, the Bloomington <italic>Drosophila</italic> Stock Center, the National Institute of Genetics Stock Center (NIG-FLY), the <italic>Drosophila</italic> Genomics and Genetic Resources (DGGR, Kyoto Institute of Technology), the Vienna <italic>Drosophila</italic> Resource Center (VDRC), and the Core Facility of <italic>Drosophila</italic> Resource and Technology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences for fly stocks and reagents. We also thank the members of the Igaki laboratory for discussions. This work was supported by grants from the MEXT/JSPS KAKENHI (grant numbers 20H05320, 21H05284, and 21H05039) to TI, Japan Agency for Medical Research and Development (Project for Elucidating and Controlling Mechanisms of Aging and Longevity; grant number 20gm5010001) to TI, the Takeda Science Foundation to TI, the Fundamental Research Funds for the Central Universities, Sun Yat-sen University to ZW (grant number 22hytd05), and the Naito Foundation to TI. ZW was supported by JSPS Postdoctoral Fellowships for Research in Japan, and XX was supported by China Scholarship Council for Research in Japan.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi-Yamada</surname><given-names>T</given-names></name><name><surname>Gotoh</surname><given-names>T</given-names></name><name><surname>Sugimura</surname><given-names>I</given-names></name><name><surname>Tateno</surname><given-names>M</given-names></name><name><surname>Nishida</surname><given-names>Y</given-names></name><name><surname>Onuki</surname><given-names>T</given-names></name><name><surname>Date</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in <italic>Drosophila</italic> imaginal discs</article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>7276</fpage><lpage>7286</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.10.7276</pub-id><pub-id pub-id-type="pmid">10490662</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>M</given-names></name><name><surname>Potier</surname><given-names>D</given-names></name><name><surname>Romanelli</surname><given-names>L</given-names></name><name><surname>Jacobs</surname><given-names>J</given-names></name><name><surname>Mach</surname><given-names>J</given-names></name><name><surname>Hamaratoglu</surname><given-names>F</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name><name><surname>Halder</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An ectopic network of transcription factors regulated by Hippo signaling drives growth and invasion of a malignant tumor model</article-title><source>Current Biology</source><volume>26</volume><fpage>2101</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2016.06.035</pub-id><pub-id pub-id-type="pmid">27476594</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beg</surname><given-names>MS</given-names></name><name><surname>Brenner</surname><given-names>AJ</given-names></name><name><surname>Sachdev</surname><given-names>J</given-names></name><name><surname>Borad</surname><given-names>M</given-names></name><name><surname>Kang</surname><given-names>YK</given-names></name><name><surname>Stoudemire</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Bader</surname><given-names>AG</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phase I study of MRX34, a liposomal miR-34a mimic, administered twice Weekly in patients with advanced solid tumors</article-title><source>Investigational New Drugs</source><volume>35</volume><fpage>180</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s10637-016-0407-y</pub-id><pub-id pub-id-type="pmid">27917453</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bode</surname><given-names>AM</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The functional contrariety of JNK</article-title><source>Molecular Carcinogenesis</source><volume>46</volume><fpage>591</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1002/mc.20348</pub-id><pub-id pub-id-type="pmid">17538955</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brumby</surname><given-names>AM</given-names></name><name><surname>Richardson</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in <italic>Drosophila</italic></article-title><source>The EMBO Journal</source><volume>22</volume><fpage>5769</fpage><lpage>5779</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg548</pub-id><pub-id pub-id-type="pmid">14592975</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bubici</surname><given-names>C</given-names></name><name><surname>Papa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Jnk signalling in cancer: in need of new, smarter therapeutic targets</article-title><source>British Journal of Pharmacology</source><volume>171</volume><fpage>24</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1111/bph.12432</pub-id><pub-id pub-id-type="pmid">24117156</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>WJ</given-names></name><name><surname>Okamura</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Endogenous RNA interference provides a somatic defense against <italic>Drosophila</italic> transposons</article-title><source>Current Biology</source><volume>18</volume><fpage>795</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2008.05.006</pub-id><pub-id pub-id-type="pmid">18501606</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croce</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oncogenes and cancer</article-title><source>The New England Journal of Medicine</source><volume>358</volume><fpage>502</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1056/NEJMra072367</pub-id><pub-id pub-id-type="pmid">18234754</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doggett</surname><given-names>K</given-names></name><name><surname>Turkel</surname><given-names>N</given-names></name><name><surname>Willoughby</surname><given-names>LF</given-names></name><name><surname>Ellul</surname><given-names>J</given-names></name><name><surname>Murray</surname><given-names>MJ</given-names></name><name><surname>Richardson</surname><given-names>HE</given-names></name><name><surname>Brumby</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Btb-Zinc finger oncogenes are required for Ras and Notch-driven tumorigenesis in <italic>Drosophila</italic></article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0132987</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0132987</pub-id><pub-id pub-id-type="pmid">26207831</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>CD</given-names></name><name><surname>Csordás</surname><given-names>G</given-names></name><name><surname>Correia</surname><given-names>A</given-names></name><name><surname>Jindra</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Habermann</surname><given-names>B</given-names></name><name><surname>Uhlirova</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Atf3 links loss of epithelial polarity to defects in cell differentiation and cytoarchitecture</article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007241</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007241</pub-id><pub-id pub-id-type="pmid">29494583</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eferl</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>EF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Ap-1: a double-edged sword in tumorigenesis</article-title><source>Nature Reviews. Cancer</source><volume>3</volume><fpage>859</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1038/nrc1209</pub-id><pub-id pub-id-type="pmid">14668816</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in <italic>Drosophila</italic></article-title><source>EMBO Reports</source><volume>14</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.185</pub-id><pub-id pub-id-type="pmid">23196366</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Siow</surname><given-names>C</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title><italic>Drosophila</italic> as a cancer model</article-title><source>Advances in Experimental Medicine and Biology</source><volume>1076</volume><fpage>173</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1007/978-981-13-0529-0_10</pub-id><pub-id pub-id-type="pmid">29951820</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Lv</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tankyrase regulates apoptosis by activating JNK signaling in <italic>Drosophila</italic></article-title><source>Biochemical and Biophysical Research Communications</source><volume>503</volume><fpage>2234</fpage><lpage>2239</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.06.143</pub-id><pub-id pub-id-type="pmid">29953853</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goode</surname><given-names>S</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Inhibition of patterned cell shape change and cell invasion by discs large during <italic>Drosophila</italic> oogenesis</article-title><source>Genes &amp; Development</source><volume>11</volume><fpage>2532</fpage><lpage>2544</lpage><pub-id pub-id-type="doi">10.1101/gad.11.19.2532</pub-id><pub-id pub-id-type="pmid">9334318</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gultekin</surname><given-names>Y</given-names></name><name><surname>Steller</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Axin proteolysis by iduna is required for the regulation of stem cell proliferation and intestinal homeostasis in <italic>Drosophila</italic></article-title><source>Development</source><volume>146</volume><elocation-id>169284</elocation-id><pub-id pub-id-type="doi">10.1242/dev.169284</pub-id><pub-id pub-id-type="pmid">30796047</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>DS</given-names></name><name><surname>Kang</surname><given-names>Y-K</given-names></name><name><surname>Borad</surname><given-names>M</given-names></name><name><surname>Sachdev</surname><given-names>J</given-names></name><name><surname>Ejadi</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>HY</given-names></name><name><surname>Brenner</surname><given-names>AJ</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>J-L</given-names></name><name><surname>Kim</surname><given-names>T-Y</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Becerra</surname><given-names>CR</given-names></name><name><surname>Falchook</surname><given-names>G</given-names></name><name><surname>Stoudemire</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><name><surname>Kelnar</surname><given-names>K</given-names></name><name><surname>Peltier</surname><given-names>H</given-names></name><name><surname>Bonato</surname><given-names>V</given-names></name><name><surname>Bader</surname><given-names>AG</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>O’Neill</surname><given-names>V</given-names></name><name><surname>Beg</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours</article-title><source>British Journal of Cancer</source><volume>122</volume><fpage>1630</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1038/s41416-020-0802-1</pub-id><pub-id pub-id-type="pmid">32238921</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>K</given-names></name><name><surname>Fostier</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Fuwa</surname><given-names>TJ</given-names></name><name><surname>Go</surname><given-names>MJ</given-names></name><name><surname>Okano</surname><given-names>H</given-names></name><name><surname>Baron</surname><given-names>M</given-names></name><name><surname>Matsuno</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title><italic>Drosophila</italic> deltex mediates suppressor of hairless-independent and late-endosomal activation of notch signaling</article-title><source>Development</source><volume>131</volume><fpage>5527</fpage><lpage>5537</lpage><pub-id pub-id-type="doi">10.1242/dev.01448</pub-id><pub-id pub-id-type="pmid">15496440</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igaki</surname><given-names>T</given-names></name><name><surname>Kanda</surname><given-names>H</given-names></name><name><surname>Yamamoto-Goto</surname><given-names>Y</given-names></name><name><surname>Kanuka</surname><given-names>H</given-names></name><name><surname>Kuranaga</surname><given-names>E</given-names></name><name><surname>Aigaki</surname><given-names>T</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Eiger, a TNF superfamily ligand that triggers the <italic>Drosophila</italic> JNK pathway</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>3009</fpage><lpage>3018</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf306</pub-id><pub-id pub-id-type="pmid">12065414</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igaki</surname><given-names>T</given-names></name><name><surname>Pagliarini</surname><given-names>RA</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Loss of cell polarity drives tumor growth and invasion through JNK activation in <italic>Drosophila</italic></article-title><source>Current Biology</source><volume>16</volume><fpage>1139</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.04.042</pub-id><pub-id pub-id-type="pmid">16753569</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igaki</surname><given-names>T</given-names></name><name><surname>Pastor-Pareja</surname><given-names>JC</given-names></name><name><surname>Aonuma</surname><given-names>H</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Intrinsic tumor suppression and epithelial maintenance by endocytic activation of eiger/TNF signaling in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>16</volume><fpage>458</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.01.002</pub-id><pub-id pub-id-type="pmid">19289090</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishimaru</surname><given-names>S</given-names></name><name><surname>Ueda</surname><given-names>R</given-names></name><name><surname>Hinohara</surname><given-names>Y</given-names></name><name><surname>Ohtani</surname><given-names>M</given-names></name><name><surname>Hanafusa</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Pvr plays a critical role via JNK activation in thorax closure during <italic>Drosophila</italic> metamorphosis</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>3984</fpage><lpage>3994</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600417</pub-id><pub-id pub-id-type="pmid">15457211</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Seimiya</surname><given-names>M</given-names></name><name><surname>Schlumpf</surname><given-names>TB</given-names></name><name><surname>Paro</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An intrinsic tumour eviction mechanism in <italic>Drosophila</italic> mediated by steroid hormone signalling</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3293</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05794-1</pub-id><pub-id pub-id-type="pmid">30120247</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabekkodu</surname><given-names>SP</given-names></name><name><surname>Shukla</surname><given-names>V</given-names></name><name><surname>Varghese</surname><given-names>VK</given-names></name><name><surname>D’ Souza</surname><given-names>J</given-names></name><name><surname>Chakrabarty</surname><given-names>S</given-names></name><name><surname>Satyamoorthy</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Clustered miRNAs and their role in biological functions and diseases</article-title><source>Biological Reviews of the Cambridge Philosophical Society</source><volume>93</volume><fpage>1955</fpage><lpage>1986</lpage><pub-id pub-id-type="doi">10.1111/brv.12428</pub-id><pub-id pub-id-type="pmid">29797774</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Gallagher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance</article-title><source>IUBMB Life</source><volume>57</volume><fpage>283</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1080/15216540500097111</pub-id><pub-id pub-id-type="pmid">16036612</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y-K</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>TS</given-names></name><name><surname>Park</surname><given-names>S-Y</given-names></name><name><surname>Namkoong</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Hur</surname><given-names>K</given-names></name><name><surname>Yoo</surname><given-names>M-W</given-names></name><name><surname>Lee</surname><given-names>H-J</given-names></name><name><surname>Yang</surname><given-names>H-K</given-names></name><name><surname>Kim</surname><given-names>VN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>1672</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp002</pub-id><pub-id pub-id-type="pmid">19153141</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tankyrase mediates K63-linked ubiquitination of JNK to confer stress tolerance and influence lifespan in <italic>Drosophila</italic></article-title><source>Cell Reports</source><volume>25</volume><fpage>437</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.09.036</pub-id><pub-id pub-id-type="pmid">30304683</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DUev1a modulates TNF-JNK mediated tumor progression and cell death in <italic>Drosophila</italic></article-title><source>Developmental Biology</source><volume>380</volume><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.05.013</pub-id><pub-id pub-id-type="pmid">23726905</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname><given-names>R</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Sanaki</surname><given-names>Y</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell competition is driven by autophagy</article-title><source>Developmental Cell</source><volume>51</volume><fpage>99</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.08.018</pub-id><pub-id pub-id-type="pmid">31543447</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliarini</surname><given-names>RA</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A genetic screen in <italic>Drosophila</italic> for metastatic behavior</article-title><source>Science</source><volume>302</volume><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1126/science.1088474</pub-id><pub-id pub-id-type="pmid">14551319</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>G</given-names></name><name><surname>Pel</surname><given-names>ME</given-names></name><name><surname>Kirschner</surname><given-names>MB</given-names></name><name><surname>Cheng</surname><given-names>YY</given-names></name><name><surname>Mugridge</surname><given-names>N</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Edelman</surname><given-names>JJB</given-names></name><name><surname>Vallely</surname><given-names>MP</given-names></name><name><surname>McCaughan</surname><given-names>BC</given-names></name><name><surname>Klebe</surname><given-names>S</given-names></name><name><surname>Brahmbhatt</surname><given-names>H</given-names></name><name><surname>MacDiarmid</surname><given-names>JA</given-names></name><name><surname>van Zandwijk</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma</article-title><source>Annals of Oncology</source><volume>24</volume><fpage>3128</fpage><lpage>3135</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdt412</pub-id><pub-id pub-id-type="pmid">24148817</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryazansky</surname><given-names>SS</given-names></name><name><surname>Gvozdev</surname><given-names>VA</given-names></name><name><surname>Berezikov</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evidence for post-transcriptional regulation of clustered microRNAs in <italic>Drosophila</italic></article-title><source>BMC Genomics</source><volume>12</volume><elocation-id>371</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-12-371</pub-id><pub-id pub-id-type="pmid">21771325</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name><name><surname>Palmer</surname><given-names>WH</given-names></name><name><surname>Tamori</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>WM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Systematic analysis reveals tumor-enhancing and -suppressing microRNAs in <italic>Drosophila</italic> epithelial tumors</article-title><source>Oncotarget</source><volume>8</volume><fpage>108825</fpage><lpage>108839</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.22226</pub-id><pub-id pub-id-type="pmid">29312571</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamori</surname><given-names>Y</given-names></name><name><surname>Bialucha</surname><given-names>CU</given-names></name><name><surname>Tian</surname><given-names>AG</given-names></name><name><surname>Kajita</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name><name><surname>Norman</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>N</given-names></name><name><surname>Poulton</surname><given-names>J</given-names></name><name><surname>Ivanovitch</surname><given-names>K</given-names></name><name><surname>Disch</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Deng</surname><given-names>WM</given-names></name><name><surname>Fujita</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Involvement of LGL and mahjong/vprbp in cell competition</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000422</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000422</pub-id><pub-id pub-id-type="pmid">20644714</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tipping</surname><given-names>M</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Drosophila</italic> as a model for context-dependent tumorigenesis</article-title><source>Journal of Cellular Physiology</source><volume>229</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/jcp.24427</pub-id><pub-id pub-id-type="pmid">23836429</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turkel</surname><given-names>N</given-names></name><name><surname>Sahota</surname><given-names>VK</given-names></name><name><surname>Bolden</surname><given-names>JE</given-names></name><name><surname>Goulding</surname><given-names>KR</given-names></name><name><surname>Doggett</surname><given-names>K</given-names></name><name><surname>Willoughby</surname><given-names>LF</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Martin-Blanco</surname><given-names>E</given-names></name><name><surname>Corominas</surname><given-names>M</given-names></name><name><surname>Ellul</surname><given-names>J</given-names></name><name><surname>Aigaki</surname><given-names>T</given-names></name><name><surname>Richardson</surname><given-names>HE</given-names></name><name><surname>Brumby</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The BTB-zinc finger transcription factor abrupt acts as an epithelial oncogene in <italic>Drosophila melanogaster</italic> through maintaining a progenitor-like cell state</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003627</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003627</pub-id><pub-id pub-id-type="pmid">23874226</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlirova</surname><given-names>M</given-names></name><name><surname>Bohmann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Jnk- and fos-regulated MMP1 expression cooperates with Ras to induce invasive tumors in <italic>Drosophila</italic></article-title><source>The EMBO Journal</source><volume>25</volume><fpage>5294</fpage><lpage>5304</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601401</pub-id><pub-id pub-id-type="pmid">17082773</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallejo</surname><given-names>DM</given-names></name><name><surname>Caparros</surname><given-names>E</given-names></name><name><surname>Dominguez</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Targeting Notch signalling by the conserved mir-8/200 microRNA family in development and cancer cells</article-title><source>The EMBO Journal</source><volume>30</volume><fpage>756</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.358</pub-id><pub-id pub-id-type="pmid">21224847</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Zandwijk</surname><given-names>N</given-names></name><name><surname>Pavlakis</surname><given-names>N</given-names></name><name><surname>Kao</surname><given-names>SC</given-names></name><name><surname>Linton</surname><given-names>A</given-names></name><name><surname>Boyer</surname><given-names>MJ</given-names></name><name><surname>Clarke</surname><given-names>S</given-names></name><name><surname>Huynh</surname><given-names>Y</given-names></name><name><surname>Chrzanowska</surname><given-names>A</given-names></name><name><surname>Fulham</surname><given-names>MJ</given-names></name><name><surname>Bailey</surname><given-names>DL</given-names></name><name><surname>Cooper</surname><given-names>WA</given-names></name><name><surname>Kritharides</surname><given-names>L</given-names></name><name><surname>Ridley</surname><given-names>L</given-names></name><name><surname>Pattison</surname><given-names>ST</given-names></name><name><surname>MacDiarmid</surname><given-names>J</given-names></name><name><surname>Brahmbhatt</surname><given-names>H</given-names></name><name><surname>Reid</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Safety and activity of microrna-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study</article-title><source>The Lancet. Oncology</source><volume>18</volume><fpage>1386</fpage><lpage>1396</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(17)30621-6</pub-id><pub-id pub-id-type="pmid">28870611</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>MicroRNAs in the same clusters evolve to coordinately regulate functionally related genes</article-title><source>Molecular Biology and Evolution</source><volume>33</volume><fpage>2232</fpage><lpage>2247</lpage><pub-id pub-id-type="doi">10.1093/molbev/msw089</pub-id><pub-id pub-id-type="pmid">27189568</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CW</given-names></name><name><surname>Purkayastha</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>KT</given-names></name><name><surname>Thaker</surname><given-names>SK</given-names></name><name><surname>Banerjee</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>In vivo genetic dissection of tumor growth and the warburg effect</article-title><source>eLife</source><volume>5</volume><elocation-id>e18126</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18126</pub-id><pub-id pub-id-type="pmid">27585295</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tacchelly-Benites</surname><given-names>O</given-names></name><name><surname>Noble</surname><given-names>GP</given-names></name><name><surname>Johnson</surname><given-names>MK</given-names></name><name><surname>Gagné</surname><given-names>JP</given-names></name><name><surname>Poirier</surname><given-names>GG</given-names></name><name><surname>Ahmed</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A context-dependent role for the RNF146 ubiquitin ligase in wingless/wnt signaling in <italic>Drosophila</italic></article-title><source>Genetics</source><volume>211</volume><fpage>913</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1534/genetics.118.301393</pub-id><pub-id pub-id-type="pmid">30593492</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wills</surname><given-names>Z</given-names></name><name><surname>Bateman</surname><given-names>J</given-names></name><name><surname>Korey</surname><given-names>CA</given-names></name><name><surname>Comer</surname><given-names>A</given-names></name><name><surname>Van Vactor</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The tyrosine kinase Abl and its substrate enabled collaborate with the receptor phosphatase Dlar to control motor axon guidance</article-title><source>Neuron</source><volume>22</volume><fpage>301</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/s0896-6273(00)81091-0</pub-id><pub-id pub-id-type="pmid">10069336</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Kuca</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Jnk signaling in cancer cell survival</article-title><source>Medicinal Research Reviews</source><volume>39</volume><fpage>2082</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.1002/med.21574</pub-id><pub-id pub-id-type="pmid">30912203</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>L</given-names></name><name><surname>Igaki</surname><given-names>T</given-names></name><name><surname>Kuranaga</surname><given-names>E</given-names></name><name><surname>Kanda</surname><given-names>H</given-names></name><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Tumor suppressor CYLD regulates JNK-induced cell death in <italic>Drosophila</italic></article-title><source>Developmental Cell</source><volume>13</volume><fpage>446</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2007.07.012</pub-id><pub-id pub-id-type="pmid">17765686</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>Q</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Clustered microRNAs’ coordination in regulating protein-protein interaction network</article-title><source>BMC Systems Biology</source><volume>3</volume><elocation-id>65</elocation-id><pub-id pub-id-type="doi">10.1186/1752-0509-3-65</pub-id><pub-id pub-id-type="pmid">19558649</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeitlinger</surname><given-names>J</given-names></name><name><surname>Bohmann</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Thorax closure in <italic>Drosophila</italic>: involvement of fos and the JNK pathway</article-title><source>Development</source><volume>126</volume><fpage>3947</fpage><lpage>3956</lpage><pub-id pub-id-type="doi">10.1242/dev.126.17.3947</pub-id><pub-id pub-id-type="pmid">10433922</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Drosophila melanogaster</italic>)</td><td align="left" valign="bottom">dlg<sup>m52</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9334318/">9334318</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">puc-lacZ</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16753569/">16753569</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Ras<sup>v12</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16753569/">16753569</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Bsk<sup>DN</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10490662/">10490662</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Src64B</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10069336/">10069336</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Hel25E<sup>ccp-8</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31543447/">31543447</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">Mahj<sup>1</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20644714/">20644714</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-N<sup>act</sup></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15496440/">15496440</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-RNF146</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30796047/">30796047</ext-link></td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">lgl<sup>4</sup></td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:36289</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-p35</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:5073</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-PVR<sup>act</sup></td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:58496</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Yki<sup>S168A</sup></td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:28836</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Luciferase</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:35788</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-RFP</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:30556</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-bantam</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:60672</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-9c,306,79,9b</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41156</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-79</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41145</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-2a-2,2a-1,2b-2</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:59849</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-2b-1</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41128</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-7</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41137</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-8</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41176</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-9a</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41138</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-9b</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41131</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-9c</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41139</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-11</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:59865</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-12</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41140</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-13a,13b-1,2c</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:64097</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-13b-2</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:59867</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-14</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41178</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-34</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41158</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-92a</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41153</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-124</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41126</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-184</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41174</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-252</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41127</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-276a</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41143</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-276b</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41162</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-278</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41180</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-279</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41147</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-282</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41165</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-305</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41152</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-310</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41155</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-317</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:59913</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-958</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41222</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-975,976,977</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:60635</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-981</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:60639</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-984</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41224</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-988</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41196</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-995</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:41199</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-996</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:60653</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-998</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:63043</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-306-sponge</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:61424</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-79-sponge</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:61387</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Luciferase RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:31603</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-aop RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:34909</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-pde1c RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:55925</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-atf3 RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:26741</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-mei-P26 RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:57268</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-chn RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:26779</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-chinmo RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:26777</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-RNF146 RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:40882</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-bcd RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:33886</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-CG1358 RNAi</td><td align="left" valign="bottom">Bloomington Drosophila Stock Center</td><td align="left" valign="bottom">BDSC:64848</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-miR-306</td><td align="left" valign="bottom">FlyORF</td><td align="left" valign="bottom">FlyORF: F002214</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">UAS-Tnks</td><td align="left" valign="bottom">Core Facility of <italic>Drosophila</italic> Resource and Technology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>D. melanogaster</italic>)</td><td align="left" valign="bottom">S2</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">Cat #CRL-1963</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-JNK (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #4668</td><td align="char" char="." valign="bottom">1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-galactosidase (chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat #ab9361</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-cleaved <italic>Drosophila</italic> Dcp-1 (Asp216) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #9578</td><td align="char" char="." valign="bottom">1:100</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit secondary antibody, Alexa Fluor 647</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #A32733</td><td align="char" char="." valign="bottom">1:250</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-chicken secondary antibody, Alexa Fluor 647</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #A21449</td><td align="char" char="." valign="bottom">1:250</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-α-tubulin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat #T5168</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-JNK (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #9251</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-JNK (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat #sc-7345</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RNF146 (rabbit polyclonal)</td><td align="left" valign="bottom">GenScript antibody service</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Raised in rabbits against peptide HSGGGSGEDPAVGSC,1:2000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-V5 tag (mouse monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #R960-25</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-myc tag (rabbit polyclonal)</td><td align="left" valign="bottom">MBL</td><td align="left" valign="bottom">Cat #562</td><td align="char" char="." valign="bottom">1:1000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Horse anti-mouse IgG, HRP-linked antibody</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #7076</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Goat anti-rabbit IgG, HRP-linked antibody</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat #7074</td><td align="char" char="." valign="bottom">1:5000</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DAPI-containing SlowFade Gold Antifade Reagent</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat #S36937</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">FuGene HD transfection reagent</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat #PRE2311</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">CHX</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat #SC-3508</td><td align="left" valign="bottom">50 μg/ml</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77340.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.02.11.480121" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.11.480121"/></front-stub><body><p>This article is valuable as it uncovers a previously unknown tumor-suppressor mechanism that eliminates <italic>JNK</italic>-activated <italic>Drosophila</italic> tumors. This mechanism is triggered by the overexpression of microRNAs that downregulate an E3 ubiquitin ligase RNF146, whose loss causes an increase in Tnks (poly-ADP-ribose polymerases) and <italic>JNK</italic> signaling. This tumor-suppressor mechanism has potential implications for the treatment of <italic>JNK</italic>-activated tumors. This article is of interest to people in the tumor suppressor, <italic>JNK</italic>, and miRNA fields, and the key claims are convincing and well supported by the data, and the authors use thoughtful and rigorous approaches.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77340.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bach</surname><given-names>Erika A</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0190ak572</institution-id><institution>New York University School of Medicine</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.11.480121">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.11.480121v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Tumor elimination by clustered microRNAs miR-306 and miR-79 via non-canonical activation of <italic>JNK</italic> signaling&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Erika A Bach as Reviewing Editor and (Reviewer #1), and the evaluation has been overseen by Utpal Banerjee as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Show whether 1x or 2x copies of miR-306 or miR-79 cause death in larval or pupal eye discs.</p><p>2. Assess whether Rnf146 protein increases in miR 9c/306/79/9b loss-of-function clones in the eye disc.</p><p>3. Ensure that the same number of UAS transgenes are present in genotypes that are being compared; this might result in repeating experiments.</p><p>4. Improve Western blots of pJNK by normalizing to the level of total <italic>JNK</italic> (not α-tubulin) in the sample and increasing sample size to at least three independent replicates. The Western blot data should be displayed as a graph of normalized p-<italic>JNK</italic> levels with error bars and statistics.</p><p>5. Improve the Rnf146 Western blot in Figure 5F. At a bare minimum, there should be at least three replicates and quantification in a graph.</p><p>6. Assess whether these miRNAs enhance normally-occurring <italic>JNK</italic> activity, for example during dorsal closure in the embryo.</p><p>7. Many controls are not shown. These include but are not limited to:</p><p>– Figure 1 needs wild-type control (Luc) clones and quantification.</p><p>– Figure 2 needs wild-type control (Luc) clones and quantification (to the block of panels in Figure 2A-E) and p35-expressing clones and quantification (to the block of panels in Figure 2. F-I).</p><p>– Figure 3 needs wild-type control clones (Luc alone), and p35-expressing clones the first block of panels (A-I). In the Q-X section, the authors should add Luc alone clones, bsk-DN clones, Ras/dlg clones with quantification. M-P should show control eyes (GMR/+).</p><p>– Figure 4 A-E and Figure 4-Figure Sup 1, wild-type control clones are required.</p><p>– Figure 5, Ras-Dlg and dRNF146-OE clones should be included.</p><p>– Figure 6C, D, should include Tnks alone expressing clones.</p><p>8. Show expression of <italic>JNK</italic> targets – TRE-reporters, pJNK, or puc-lacZ – in miR-306 and 79 clones and in PVR-act, Src64B, Hel25E, and Mahj clones.</p><p>9. Show that miR-306 and 79 enhance <italic>JNK</italic> activity in Ras-Dlg tumors by showing the expression of <italic>JNK</italic> targets as the TRE-reporters, pJNK, or puc-lacZ.</p><p>10. Show that Ras-Dlg+miR-306/79+dRNF146 clones are the same size as the Ras-Dlg clones. Currently, this does not seem to be the case (compare Fig5G with Figure 5K or M).</p><p>11. Show that <italic>JNK</italic> activity levels are upregulated when dRNF146 is downregulated in those tumors.</p><p>12. Show that Tnks overexpression alone does not affect normal growth in otherwise wild-type clones.</p><p>13. Show that miR-309/79 modulation affects Tnks protein levels.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>In the current study, Wang and colleagues perform a microRNA (miR) screen to find miRs that can suppress tumors caused by RasV12 and loss of polarity genes (i.e., discs large (dlg) or lethal giant larva (lgl)). This screen identified 12 miRs that when overexpressed suppressed the growth of RasV12 dlg-/- (or lgl-/-) tumors in the eye disc. They went on to characterize a cluster called miR 9c/306/79/9b. Clonal overexpression of miR-306 or miR-79 suppressed the tumors but did not greatly suppress growth of wild-type tissue. The authors went on to show that clonal overexpression of miR-306 or of miR-79 caused cell death in the tumors but did not cause death in WT tissue. Further experiments revealed that these miRs interact with cell polarity and not with RasV12. The authors then show that these miRs cause up regulation of <italic>JNK</italic> signaling as inhibiting <italic>JNK</italic> signaling abrogated the tumor-suppressing ability of these miRs. These miRs also enhanced <italic>JNK</italic> signaling in several other kinds of tumors that depend on <italic>JNK</italic>. They use an algorithm targetscanfly to search for miR binding sites and found 11 mRNAs that were predicted to be targets of both miR-306 and miR-79. They were able to test nine of these genes through RNA interference and only one of them Rnf146 caused <italic>JNK</italic> activation when depleted. They used luciferase assays in cultured cells to show that there were two binding sites in the 3'UTR of Rnf146 for these miRs. Knockdown of Rnf146 did not block the growth of normal tissue but it did significantly suppress the growth of RasV12 dlg-/- mutant cells. Rnf146 is a ubiquitin ligase that interacts with tankyrases (TNKs) – poly-ADP-ribose polymerases – to target proteins for degradation, and the authors next examined the role of TNKs in their tumor model. They used biochemistry to show that TNKs activate <italic>JNK</italic> by phosphorylation in S2 cells and that RNF146 downregulates TNK protein as well as <italic>JNK</italic> activation. Overexpression of TNKs in tumors suppresses their growth. Finally, they used biochemistry to show that when they blocked protein synthesis and depleted Rnf146, TNK protein levels remained relatively stable. These data support their model that miR-306 and -79 directly target Rnf146, which results in elevated TNK and this induces <italic>JNK</italic> signaling to cause cell death.</p><p>The novelty of this study is finding the connection between miR-306 and miR-79 and Rnf146. By contrast, it was already known that TNKs activates <italic>JNK</italic> signaling (Feng et al. 2018; Li et al. 2018) and that Rnf146 degrades TNKs (Gultekin, Y., Steller, H., 2019, Figure S2E-F, PMID: 30796047). The lattermost result is not acknowledged by the authors. Gultekin and Steller mis-expressed TNKs in eye discs in a WT or an RNF146 mutant background (Iduna-/- which is adult viable) and then performed Western blots on eye discs. They found that TNK protein levels were significantly higher in the Rnf146 mutant background than in WT.</p><p>There are several issues that I think should be addressed.</p><p>Issues with experiments/text:</p><p>1. The authors should acknowledge the results of Gultekin and Steller in the manuscript and compare results.</p><p>2. The authors state that over-expression of miR-306 or miR-79 (presumably using 1 copy of the transgene) does not reduce growth or WT cells. However, the results in Figure 5, figure supplement 3G-J does not support this model. In these experiments, the authors over-expressed 2 copies of UAS-miR and adult eyes from GMR&gt;2x miR-306 or GMR&gt;2x miR-79 are noticeably smaller than WT and are rough. These results suggest that miR-306 and miR-79 do indeed affect WT cells, which then may make it less likely that miR over-expression can be used as cancer therapy. Can the authors examine death cells in GMR&gt;2x miR-306 or GMR&gt;2x miR-79 larval or pupal discs? Alternatively, what happens when only 1 copy of the UAS-miR is over-expressed?</p><p>3. The authors depleted Rnf146 from GMR&gt;Eiger and saw an enhancement of the eye phenotype. I might be confused, but I thought that it would be better to over-express Rnf146 in GMR&gt;Eiger and look for suppression of the small eye phenotype.</p><p>4. Most of the experiments are over-expression. Does miR-306 or miR-79 normally regulate levels of Rnf-146 protein? Can you make a clone of the miR 9c/306/79/9b and see Rnf146 protein levels increase?</p><p>5. The Rnf146 null allele is adult viable. It might be beyond the scope of this work, but if you made RasV12, dlg-/- clones in an Rnf146 null mutant, the tumors should significantly smaller than in a heterozygous background.</p><p>Issues with figures:</p><p>1. Figure 1, figure supplement 1, panel AI: the authors need to mention that the dashed horizontal line at 60% comes from the RasV12 dlg-/- clones in Figure 1F.</p><p>2. Figure 2: Please show Dcp-1 in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>3. Figure 2: panel I – there should be the same number of UAS transgenes in all the genotypes.</p><p>4. 4. Figure 2, figure supplement 1: Please show Dcp-1 in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>5. Figure 3: panels T and X, there should be the same number of UAS transgenes in all the genotypes.</p><p>6. Figure 3, panel J: The authors should show a close up of pJNK in WT wing discs with Luc clones as panel J&quot;.</p><p>7. Figure 3, figure supplement 2, panel A: The authors should show a close up of pJNK in WT wing discs with Luc clones as panel A&quot;.</p><p>8. Figure 3, figure supplement 2, panel D: There are several issues with this figure. (1) pJNK levels should be normalize to the level of total <italic>JNK</italic> in the sample. It is possible that the lower level of pJNK is a result of less <italic>JNK</italic> protein in GMR&gt;Luc compared to <italic>JNK</italic> in GMR&gt;miR-306 or GMR-miR-79 and knowing the total level of <italic>JNK</italic> protein in these cells would allow them to disprove this possibility. Currently, the authors normalize with α-tubulin. (2) The Western blot data should be displayed as a graph of normalized p-<italic>JNK</italic> levels with error bars and statistics.</p><p>9. Figure 5, panels B' and C': Please show puc-lacZ in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>10. Figure 5, panel F: The Western blot data should be displayed as a graph of normalized dRNF146 levels with error bars and statistics.</p><p>11. Figure 5, figure supplement 1, panels A'-F': Please show puc-lacZ in red or magenta as it is very difficult to see white on green.</p><p>12. The source files are in a.gel format, which I cannot access. Would you please upload them as.tif or.jpeg?</p><p>13. Include a file with complete genotypes for all figures.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is a very complete manuscript. It requires only very few revisions and is appropriate for eLife.</p><p>1. The authors showed that overexpression of miR-79 and -306 alone was not sufficient to induce a significant phenotype on eye morphology. However, JNK activity is usually not active in eye discs and therefore it cannot be further enhanced. Can expression of these miRNAs enhance normally occurring JNK activity during normal development? One example where the author can address this question is dorsal closure during embryogenesis.</p><p>2. The authors mention that Tankyrase promotes K63-polyubiquitylation of JNK. Is it known how Tankyrase mediates this effect? Even if not, it is worth mentioning this in the text.</p><p>3. The authors did an excellent job in quantifying every experiment shown. However, in the Method section, they did not explain how the expression levels (Dcp-1, pJNK, puc-lacZ, etc.) were measured and quantified.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The experiments presented lack some controls. This will allow a more complete comparison between the genetic conditions analyzed.</p><p>– Figure 1 should show, as panel A, wild type control clones (Luc alone). The quantification of those clones should be shown in panel F.</p><p>– Figure 2: wild type control clones should be added in the 1st block of results (A-E). p35-expressing clones should be used as controls in the second group of results (F-I).</p><p>– Figure 3: the first block of results (A-I) should also include wild type control clones (Luc alone), and p35-expressing clones. In the Q-X section, Luc alone clones, bsk-DN clones, Ras/dlg clones should be shown and quantified. M-P should show control eyes (GMR/+).</p><p>– Figure 4 A-E, and Figure 4-Figure Sup 1, wild type control clones are required.</p><p>– Figure 5, Ras-Dlg and dRNF146-OE clones should be included.</p><p>– Figure 6C, D, hould include Tnks alone expressing clones.</p><p>To conclude that &quot;miR-306 and miR-79 suppress tumor growth by enhancing <italic>JNK</italic> signaling&quot;, the authors should show that miR-306 and 79 enhance <italic>JNK</italic> activity in tumors by showing the expression of <italic>JNK</italic> targets as the TRE-reporters, pJNK, or puc-lacZ.</p><p>The title of section &quot;miR-306 and miR-79 enhance <italic>JNK</italic> signaling in different types of tumors&quot; is misleading and confusing. Among the 4 conditions analyzed – namely, PVR-act, Src64B, Hel25E, and Mahj, only the PVR-act condition (although it lacks the proper control) seems to cause oncogenic growth. As previously mentioned, to claim that those miRNAs enhance <italic>JNK</italic> activity, the authors should show the expression of <italic>JNK</italic> targets as the TRE-reporters, pJNK, or puc-lacZ.</p><p>Figure 4 K-O. The authors show that &quot;non-autonomous overgrowth of surrounding wild-type tissue by Src64B-overexpressing clones&quot;. Is this observation relevant for this manuscript? It seems to come out of the blue and I can´t find the connection with the rest of results presented here.</p><p>Related to the regulation of dRNF146 by miRNA-305/79, the results shown in D and E show that the predicted binding site is sensitive to the levels of those miRNAs. However, results showing that the proposed regulation is indeed taking place in vivo and is physiologically relevant are missing. The western presented in Figure 5F is very poor. Results with better quality need to be provided to show that convincingly. In line with that, showing the protein levels in miR-306 and 79-expressing clones in the eye disc will provide a convincing piece of data.</p><p>The authors claim: &quot;Furthermore, overexpression of dRNF146 cancelled the tumor-suppressive effect of miR-306 or miR-79 on RasV12/dlg-/- tumors (Figure 5J-M, quantified in Figure 5N).&quot; To show that convincingly, the authors need to show that Ras-Dlg+miR-306/79+dRNF146 clones present the same size as the Ras-Dlg clones. At glance, this does not seem to be the case (compare Fig5G with Figure 5K or M).</p><p>After that, the authors state: &quot;Together, these data indicate that miR-306 and miR-79 directly target dRNF146 mRNA, thereby enhancing <italic>JNK</italic> signaling activity and thus exerting the tumor-suppressive effects.&quot; The authors make different correlations to reach that conclusion but do not show evidence proving that dRNF146 depletion is in fact enhancing <italic>JNK</italic> activity in those tumors. To conclude that, the authors should prove that <italic>JNK</italic> activity levels are upregulated when dRNF146 is downregulated in those tumors.</p><p>To demonstrate their model, the authors should show that Tnks overexpression alone does not affect normal growth in otherwise wild type clones. The authors should also show that miR-309/79 modulation affect Tnks protein levels.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77340.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Show whether 1x or 2x copies of miR-306 or miR-79 cause death in larval or pupal eye discs.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now tested whether 1x or 2x copies of miR-306 or miR-79 cause death in larval eye discs. Our data indicate that, although overexpression of one copy of miR-306 or miR-79 in the eyes had no significant effect on the number of dying cells, overexpression of 2 copies of miR-306 or miR-79 in the eyes significantly increased the number of dying cells. We have now included these new data in Figure 5—figure supplement 4G-M (quantified in Figure 5—figure supplement 4N).</p><disp-quote content-type="editor-comment"><p>2. Assess whether Rnf146 protein increases in miR 9c/306/79/9b loss-of-function clones in the eye disc.</p></disp-quote><p>We do agree with the comment that we should test whether Rnf146 protein increases when miR-306/79 is suppressed. Unfortunately, neither the previous RNF146 antibody (a gift from Hermann Steller) nor a new RNF146 antibody (raised in rabbits against the peptide HSGGGSGEDPAVGSC) worked well in the immunofluorescence assay. Therefore, as an alternative method, we performed Western blots to detect the Rnf146 protein level using the new RNF146 antibody. As shown in Figure 5—figure supplement 3 in the revised manuscript, suppression of miR-306 and miR-79 function by using miRNA sponges indeed increased the endogenous levels of RNF146 protein in the adult eyes.</p><disp-quote content-type="editor-comment"><p>3. Ensure that the same number of UAS transgenes are present in genotypes that are being compared; this might result in repeating experiments.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now performed a series of new control experiments to make the same number of UAS transgenes present in genotypes that are being compared (please see Figures 1-6) unless it is technically too difficult by <italic>Drosophila</italic> genetics in some experiments (e.g., the experiments in Figure 3—figure supplement 3).</p><disp-quote content-type="editor-comment"><p>4. Improve Western blots of pJNK by normalizing to the level of total JNK (not α-tubulin) in the sample and increasing sample size to at least three independent replicates. The Western blot data should be displayed as a graph of normalized p-JNK levels with error bars and statistics.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now repeated all the Western blot experiments that used the pJNK antibody and were normalized by the total <italic>JNK</italic> level. All the Western blot data have now been repeated for three times and displayed as a graph with error bars and statistics in the revised Figure 6, Figure 3—figure supplement 2 and Figure 6—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>5. Improve the Rnf146 Western blot in Figure 5F. At a bare minimum, there should be at least three replicates and quantification in a graph.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now used a new RNF146 antibody (raised in rabbits against the peptide HSGGGSGEDPAVGSC, GenScript antibody service, Nanjing, China). As shown in the revised Figure 5F, we believe that the data quality has now been significantly improved. We repeated this experiment for three times and quantified the data as shown in the revised Figure 5G.</p><disp-quote content-type="editor-comment"><p>6. Assess whether these miRNAs enhance normally-occurring JNK activity, for example during dorsal closure in the embryo.</p></disp-quote><p>We appreciate the valuable comment. Following the suggestion, we have now examined whether expression of these miRNAs enhance normally occurring <italic>JNK</italic> activity during normal development. The pnr-GAL4 fly strain specifically expresses GAL4 in the wing discs in a broad domain corresponding to the central presumptive notum during metamorphosis. Knocking down <italic>Hep</italic>, the <italic>Drosophila JNK</italic> kinase, using the pnr-GAL4 driver generates a split-thorax phenotype caused by reduced <italic>JNK</italic> signaling. On the contrary, overexpression of <italic>Hep</italic> or Eiger, the <italic>Drosophila</italic> TNF that activates <italic>JNK</italic> signaling, using pnr-GAL4 generates a small-scutellum phenotype caused by elevated <italic>JNK</italic> signaling. Similar to the <italic>Hep</italic> or Eiger-induced phanotype, ectopic expression of miR-306 or 79 by the pnr-GAL4 driver resulted in a small-scutellum phenotype, indicating that miR-306/79 enhances normally-occurring <italic>JNK</italic> activity. We have now included these new data as Figure 4—figure supplement 3A-C (quantified in Figure 4—figure supplement 3D) in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>7. Many controls are not shown. These include but are not limited to:</p><p>– Figure 1 needs wild-type control (Luc) clones and quantification.</p><p>– Figure 2 needs wild-type control (Luc) clones and quantification (to the block of panels in Figure 2A-E) and p35-expressing clones and quantification (to the block of panels in Figure 2. F-I).</p><p>– Figure 3 needs wild-type control clones (Luc alone), and p35-expressing clones the first block of panels (A-I). In the Q-X section, the authors should add Luc alone clones, bsk-DN clones, Ras/dlg clones with quantification. M-P should show control eyes (GMR/+).</p><p>– Figure 4 A-E and Figure 4-Figure Sup 1, wild-type control clones are required.</p><p>– Figure 5, Ras-Dlg and dRNF146-OE clones should be included.</p><p>– Figure 6C, D, should include Tnks alone expressing clones.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now added new controls in the revised Figures (please see Figures 1-6).</p><disp-quote content-type="editor-comment"><p>8. Show expression of JNK targets – TRE-reporters, pJNK, or puc-lacZ – in miR-306 and 79 clones and in PVR-act, Src64B, Hel25E, and Mahj clones.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now tested whether miR-306 and 79 enhance <italic>JNK</italic> activity in all these tumors or cell competition models using the pJNK antibody. As shown in the revised Figure 4—figure supplement 2D-P, miR-306 or 79 indeed enhanced <italic>JNK</italic> activity in all these tumors or cell competition models.</p><disp-quote content-type="editor-comment"><p>9. Show that miR-306 and 79 enhance JNK activity in Ras-Dlg tumors by showing the expression of JNK targets as the TRE-reporters, pJNK, or puc-lacZ.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now tested whether miR-306 and 79 enhance <italic>JNK</italic> activity in Ras-Dlg tumors using the pJNK antibody. As shown in the revised Figure 4—figure supplement 2A-C (quantified in 2P), both miR-306 and 79 enhanced <italic>JNK</italic> activity in Ras-Dlg tumors.</p><disp-quote content-type="editor-comment"><p>10. Show that Ras-Dlg+miR-306/79+dRNF146 clones are the same size as the Ras-Dlg clones. Currently, this does not seem to be the case (compare Fig5G with Figure 5K or M).</p></disp-quote><p>We sincerely thank the reviewers and editors for the comment. We indeed noticed that Ras-Dlg+miR-306/79+dRNF146 clones are smaller than Ras-Dlg clones. We have now added a discussion for the possible reason for this phenomenon in the second paragraph of the “Discussion” section in the revised manuscript. Our study identified several putative co-target genes of miR-306 and miR-79 (Figure 5A). Interestingly, some of these genes (Atf3, chinmo, and chn) have been reported to be involved in tumor growth in <italic>Drosophila</italic>. Atf3 encodes an AP-1 transcription factor, which was shown to be a polarity-loss responsive gene acting downstream of the membrane-associated Scrib polarity complex (Donohoe et al., 2018). Knockdown of Atf3 suppresses growth and invasion of Ras<sup>V12</sup>/scrib<sup>-/-</sup> tumors in the eye-antennal discs (Atkins et al., 2016). Chinmo is a BTB-zinc finger oncogene that is up-regulated by <italic>JNK</italic> signaling in tumors (Doggett et al., 2015). Although loss of chinmo does not significantly suppress tumor growth, overexpression of chinmo with Ras<sup>V12</sup> or activated Notch is sufficient to promote tumor growth in the eye-antennal discs (Doggett et al., 2015). Chn encodes a zinc finger transcription factor that cooperates with scrib<sup>-/-</sup> to promote tumor growth (Turkel et al., 2013). Although we found that knockdown of these genes did not activate <italic>JNK</italic> signaling, it is possible that these putative target genes also contribute to the miR-306/miR-79-induced tumor suppression and therefore Ras-Dlg+miR-306/79+dRNF146 clones are smaller than Ras-Dlg clones.</p><disp-quote content-type="editor-comment"><p>11. Show that JNK activity levels are upregulated when dRNF146 is downregulated in those tumors.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now tested whether <italic>JNK</italic> activity levels are upregulated when dRNF146 is downregulated in Ras-Dlg tumors using the pJNK antibody. As shown in the revised Figure 5—figure supplement 5, knocking down RNF146 indeed enhanced <italic>JNK</italic> activity in Ras-Dlg tumors.</p><disp-quote content-type="editor-comment"><p>12. Show that Tnks overexpression alone does not affect normal growth in otherwise wild-type clones.</p></disp-quote><p>We sincerely thank the reviewers and editors for the comment. Following the suggestion, we have now tested whether Tnks overexpression alone affect normal growth. As shown in Figure 6G-H, Tnks overexpression alone resulted in smaller clone size compared to control. However, considering that overexpression of Tnks alone shows larger clone size than Ras<sup>V12</sup>/dlg<sup>-/-</sup>+Tnks (Figure 6H and J, quantified in Figure 6K), we believe that Tnks suppresses growth of Ras<sup>V12</sup>/dlg<sup>-/-</sup> tumors by cooperating with <italic>JNK</italic> signaling.</p><disp-quote content-type="editor-comment"><p>13. Show that miR-309/79 modulation affects Tnks protein levels.</p></disp-quote><p>We agree with the comment. Following the suggestion, we have now analyzed the Tnks protein levels when miR-306 or 79 is overexpressed. As shown in Figure 6—figure supplement 1, overexpression of miR-306 or 79 indeed significantly upregulated the Tnks protein level.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>There are several issues that I think should be addressed.</p><p>Issues with experiments/text:</p><p>1. The authors should acknowledge the results of Gultekin and Steller in the manuscript and compare results.</p></disp-quote><p>We agree with the comment. Actually, we had already described the results of Gultekin and Steller in the first paragraph of the “RNF146 promotes Tnks degradation” part of the “Results” section. However, following the suggestion, we have now added a sentence “A pervious study has indicated that Tnks protein levels were significantly higher in the Rnf146 mutant background than in wild-type (Gultekin and Steller, 2019).” in the second paragraph of the same part.</p><p>The main difference between their and our studies is that their study did not clarify whether the up-regulation of Tnks is caused by either elevated Tnks protein synthesis or reduced Tnks protein degradation. In our study, using the cycloheximide (CHX) assay, we clarified that RNF146 promotes the degradation of Tnks protein.</p><disp-quote content-type="editor-comment"><p>2. The authors state that over-expression of miR-306 or miR-79 (presumably using 1 copy of the transgene) does not reduce growth or WT cells. However, the results in Figure 5, figure supplement 3G-J does not support this model. In these experiments, the authors over-expressed 2 copies of UAS-miR and adult eyes from GMR&gt;2x miR-306 or GMR&gt;2x miR-79 are noticeably smaller than WT and are rough. These results suggest that miR-306 and miR-79 do indeed affect WT cells, which then may make it less likely that miR over-expression can be used as cancer therapy. Can the authors examine death cells in GMR&gt;2x miR-306 or GMR&gt;2x miR-79 larval or pupal discs? Alternatively, what happens when only 1 copy of the UAS-miR is over-expressed?</p></disp-quote><p>We agree with the comment. As responded in the Essential Revisions #1, although overexpression of one copy of miR-306 or miR-79 in the eyes had no significant effect on the number of dying cells, overexpression of 2×miR-306 or 2×miR-79 significantly increased the number of dying cells (Figure 5—figure supplement 4G-M, quantified in Figure 5—figure supplement 4N).</p><disp-quote content-type="editor-comment"><p>3. The authors depleted Rnf146 from GMR&gt;Eiger and saw an enhancement of the eye phenotype. I might be confused, but I thought that it would be better to over-express Rnf146 in GMR&gt;Eiger and look for suppression of the small eye phenotype.</p></disp-quote><p>We thank the reviewer for the comment. Our aim was to prove that depletion of Rnf146 have similar effect on the eye phenotype with overexpression of miR-306 or miR-79. Since Rnf146 is a component of the non-canonical <italic>JNK</italic> pathway, a lateral branch but not the major JNKKK-JNKK-<italic>JNK</italic> pathway, overexpression of Rnf146 may not be strong enough to suppress GMR&gt;Eiger induced small-eye phenotype.</p><disp-quote content-type="editor-comment"><p>4. Most of the experiments are over-expression. Does miR-306 or miR-79 normally regulate levels of Rnf-146 protein? Can you make a clone of the miR 9c/306/79/9b and see Rnf146 protein levels increase?</p></disp-quote><p>We agree with the comment. As responded in the Essential Revisions #2, neither the previous RNF146 antibody (a gift from Hermann Steller) nor the new RNF146 antibody (raised in rabbits against the peptide HSGGGSGEDPAVGSC) worked well in the immunofluorescence assay. As an alternative method, we performed Western blots to detect the Rnf146 protein levels using the new RNF146 antibody. As shown in Figure 5—figure supplement 3, suppression of miR-306 and miR-79 function using miRNA sponges indeed promoted the endogenous levels of RNF146 protein in adult eyes.</p><disp-quote content-type="editor-comment"><p>5. The Rnf146 null allele is adult viable. It might be beyond the scope of this work, but if you made RasV12, dlg-/- clones in an Rnf146 null mutant, the tumors should significantly smaller than in a heterozygous background.</p></disp-quote><p>We sincerely thank the reviewer for the comment. However, it turned out that it is so hard to generate Ras<sup>V12</sup>+dlg<sup>-/-</sup> clones in Rnf146<sup>-/-</sup> larvae. We have tried to establish flies for several times, but we were not able to succeed in making dlg<sup>m52</sup>, FRT19A; UAS-Ras<sup>V12</sup>; Rnf146<sup>-</sup>/TM6B or TM3 flies.</p><disp-quote content-type="editor-comment"><p>Issues with figures:</p><p>1. Figure 1, figure supplement 1, panel AI: the authors need to mention that the dashed horizontal line at 60% comes from the RasV12 dlg-/- clones in Figure 1F.</p><p>2. Figure 2: Please show Dcp-1 in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>3. Figure 2: panel I – there should be the same number of UAS transgenes in all the genotypes.</p><p>4. 4. Figure 2, figure supplement 1: Please show Dcp-1 in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>5. Figure 3: panels T and X, there should be the same number of UAS transgenes in all the genotypes.</p><p>6. Figure 3, panel J: The authors should show a close up of pJNK in WT wing discs with Luc clones as panel J&quot;.</p><p>7. Figure 3, figure supplement 2, panel A: The authors should show a close up of pJNK in WT wing discs with Luc clones as panel A&quot;.</p><p>8. Figure 3, figure supplement 2, panel D: There are several issues with this figure. (1) pJNK levels should be normalize to the level of total JNK in the sample. It is possible that the lower level of pJNK is a result of less JNK protein in GMR&gt;Luc compared to JNK in GMR&gt;miR-306 or GMR-miR-79 and knowing the total level of JNK protein in these cells would allow them to disprove this possibility. Currently, the authors normalize with α-tubulin. (2) The Western blot data should be displayed as a graph of normalized p-JNK levels with error bars and statistics.</p><p>9. Figure 5, panels B' and C': Please show puc-lacZ in red or magenta in panels A'-D' as it is very difficult to see white on green.</p><p>10. Figure 5, panel F: The Western blot data should be displayed as a graph of normalized dRNF146 levels with error bars and statistics.</p><p>11. Figure 5, figure supplement 1, panels A'-F': Please show puc-lacZ in red or magenta as it is very difficult to see white on green.</p><p>12. The source files are in a.gel format, which I cannot access. Would you please upload them as.tif or.jpeg?</p><p>13. Include a file with complete genotypes for all figures.</p></disp-quote><p>We sincerely thank the reviewer for the comments. Following the suggestions, we have now added new data, revised the figures and descriptions, uploaded the source files for Western blots as.tif, and included files with complete genotypes for each figure as source files in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is a very complete manuscript. It requires only very few revisions and is appropriate for eLife.</p><p>1. The authors showed that overexpression of miR-79 and -306 alone was not sufficient to induce a significant phenotype on eye morphology. However, JNK activity is usually not active in eye discs and therefore it cannot be further enhanced. Can expression of these miRNAs enhance normally occurring JNK activity during normal development? One example where the author can address this question is dorsal closure during embryogenesis.</p></disp-quote><p>We appreciate the valuable comment. As responded in the Essential Revisions #6, we have now examined whether expression of these miRNAs enhance normally occurring JNK activity during normal development. The pnr-GAL4 driver strain specifically expresses GAL4 in the wing discs in a broad domain corresponding to the central presumptive notum during metamorphosis. Knocking down Hep, the <italic>Drosophila</italic> JNK kinase, using the pnr-GAL4 driver generates a split-thorax phenotype caused by suppressing JNK signaling. On the contrary, ectopic expression of Hep or Eiger using pnr-GAL4 generates a small-scutellum phenotype caused by activation of JNK signaling. Similarly to Hep or Eiger overexpression, ectopic expression of miR-306 or 79 driven by pnr-GAL4 resulted in a small-scutellum phenotype (please see Figure 4—figure supplement 3A-C, quantified in Figure 4—figure supplement 3D in the revised manuscript). These data indicate that miR-306/79 enhances normally-occurring JNK activity.</p><disp-quote content-type="editor-comment"><p>2. The authors mention that Tankyrase promotes K63-polyubiquitylation of JNK. Is it known how Tankyrase mediates this effect? Even if not, it is worth mentioning this in the text.</p></disp-quote><p>We thank the reviewer for the comment. As reported by Ping Li et al., Tnks mediates Poly-ADP ribosylation of JNK, triggers K63-linked poly-ubiquitination of JNK and thereby enhances JNK kinase activity (Li et al., 2018). Following this suggestion, we have now mentioned this in the “RNF146 promotes Tnks degradation” part of the “Results” section in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. The authors did an excellent job in quantifying every experiment shown. However, in the Method section, they did not explain how the expression levels (Dcp-1, pJNK, puc-lacZ, etc.) were measured and quantified.</p></disp-quote><p>We thank the reviewer for the comment. The cleaved Dcp-1-positive cell number and pJNK-positive area were calculated using ImageJ and Prism 8 (Graphpad). Following the suggestion, we have now mentioned this in the “Histology” part of the “Materials and Methods” section in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>The experiments presented lack some controls. This will allow a more complete comparison between the genetic conditions analyzed.</p><p>– Figure 1 should show, as panel A, wild type control clones (Luc alone). The quantification of those clones should be shown in panel F.</p><p>– Figure 2: wild type control clones should be added in the 1st block of results (A-E). p35-expressing clones should be used as controls in the second group of results (F-I).</p><p>– Figure 3: the first block of results (A-I) should also include wild type control clones (Luc alone), and p35-expressing clones. In the Q-X section, Luc alone clones, bsk-DN clones, Ras/dlg clones should be shown and quantified. M-P should show control eyes (GMR/+).</p><p>– Figure 4 A-E, and Figure 4-Figure Sup 1, wild type control clones are required.</p><p>– Figure 5, Ras-Dlg and dRNF146-OE clones should be included.</p><p>– Figure 6C, D, hould include Tnks alone expressing clones.</p></disp-quote><p>We sincerely thank the reviewer for these comments. Following the suggestion, we have now added many controls and revised the figures in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>To conclude that &quot;miR-306 and miR-79 suppress tumor growth by enhancing JNK signaling&quot;, the authors should show that miR-306 and 79 enhance JNK activity in tumors by showing the expression of JNK targets as the TRE-reporters, pJNK, or puc-lacZ.</p></disp-quote><p>We agree with the comment. Following the suggestion, as responded in the Essential Revisions #9, we have now tested whether miR-306 and 79 enhance <italic>JNK</italic> activity in Ras-Dlg tumors using the pJNK antibody. As shown in the revised Figure 4—figure supplement 2A-C, both miR-306 and 79 indeed enhanced <italic>JNK</italic> activity in Ras-Dlg tumors.</p><disp-quote content-type="editor-comment"><p>The title of section &quot;miR-306 and miR-79 enhance JNK signaling in different types of tumors&quot; is misleading and confusing. Among the 4 conditions analyzed – namely, PVR-act, Src64B, Hel25E, and Mahj, only the PVR-act condition (although it lacks the proper control) seems to cause oncogenic growth. As previously mentioned, to claim that those miRNAs enhance JNK activity, the authors should show the expression of JNK targets as the TRE-reporters, pJNK, or puc-lacZ.</p></disp-quote><p>We appreciate the valuable comment. We have now revised the title to “miR-306 and miR-79 enhance <italic>JNK</italic> signaling stimulated by different upstream signaling”. Following the suggestion, as responded in the Essential Revisions #8, we have now tested whether miR-306 and 79 enhance <italic>JNK</italic> activity in all these tumors or cell competition models using the pJNK antibody. As shown in the revised Figure 4—figure supplement 2D-O, miR-306 or 79 indeed enhanced <italic>JNK</italic> activity in all these tumors or cell competition models.</p><disp-quote content-type="editor-comment"><p>Figure 4 K-O. The authors show that &quot;non-autonomous overgrowth of surrounding wild-type tissue by Src64B-overexpressing clones&quot;. Is this observation relevant for this manuscript? It seems to come out of the blue and I can´t find the connection with the rest of results presented here.</p></disp-quote><p>The non-autonomous overgrowth of surrounding wild-type tissue is caused by Src64B-overexpressing cells (Enomoto and Igaki, 2013). Coexpression of miR-9c/306/79/9b cluster, miR-306, or miR-79 kills Src64B-overexpressing cells in the eye-antennal discs (Figure 4H-L) and thus suppresses the non-autonomous overgrowth of surrounding wild-type tissue (Figure 4M-Q). This data indicated that miR-306 or miR-79 not only suppresses tumor growth caused by autonomous overgrowth (e.g., Ras<sup>V12</sup>/dlg<sup>-/-</sup>, Ras<sup>V12</sup>/lgl<sup>-/-</sup> and PVR<sup>act</sup>), but also suppresses tumor growth caused by non-autonomous overgrowth.</p><disp-quote content-type="editor-comment"><p>Related to the regulation of dRNF146 by miRNA-305/79, the results shown in D and E show that the predicted binding site is sensitive to the levels of those miRNAs. However, results showing that the proposed regulation is indeed taking place in vivo and is physiologically relevant are missing. The western presented in Figure 5F is very poor. Results with better quality need to be provided to show that convincingly. In line with that, showing the protein levels in miR-306 and 79-expressing clones in the eye disc will provide a convincing piece of data.</p></disp-quote><p>We agree with the comment. As responded in the Essential Revisions #2 and #5, we have now used a new RNF146 antibody (raised in rabbits against the peptide HSGGGSGEDPAVGSC, GenScript antibody service, Nanjing, China). As shown in the revised Figure 5F, we believe the data quality have now significantly improved. We repeated this experiment for three times and quantified the data as shown in the revised Figure 5G. Unfortunately, neither the previous RNF146 antibody (a gift from Hermann Steller) nor the new RNF146 antibody worked well in the immunofluorescence assay. As an alternative method, we performed Western blots to detect the Rnf146 protein levels using the new RNF146 antibody. As shown in Figure 5—figure supplement 3 in the revised manuscript, suppression of miR-306 and miR-79 functions using miRNA sponges indeed promoted the endogenous levels of RNF146 protein in the adult eyes.</p><disp-quote content-type="editor-comment"><p>The authors claim: &quot;Furthermore, overexpression of dRNF146 cancelled the tumor-suppressive effect of miR-306 or miR-79 on RasV12/dlg-/- tumors (Figure 5J-M, quantified in Figure 5N).&quot; To show that convincingly, the authors need to show that Ras-Dlg+miR-306/79+dRNF146 clones present the same size as the Ras-Dlg clones. At glance, this does not seem to be the case (compare Fig5G with Figure 5K or M).</p></disp-quote><p>We thank the reviewer for the comment. We have now replaced the word “cancelled” with “weakened” in the revised manuscript. As responded in the Essential Revisions #10, we indeed noticed that Ras-Dlg+miR-306/79+dRNF146 clones are smaller than Ras-Dlg clones. We have now added a discussion for the possible reason for this phenomenon in the second paragraph of the “Discussion” section in the revised manuscript. Our study identified several putative co-target genes of miR-306 and miR-79 (Figure 5A). Interestingly, some of these genes (Atf3, chinmo, and chn) have been reported to be involved in tumor growth in <italic>Drosophila</italic>. Atf3 encodes an AP-1 transcription factor which was shown to be a polarity-loss responsive gene acting downstream of the membrane-associated Scrib polarity complex (Donohoe et al., 2018). Knockdown of Atf3 suppresses growth and invasion of Ras<sup>V12</sup>/scrib<sup>-/-</sup> tumors in the eye-antennal discs (Atkins et al., 2016). Chinmo is a BTB-zinc finger oncogene that is up-regulated by <italic>JNK</italic> signaling in tumors (Doggett et al., 2015). Although loss of chinmo does not significantly suppress tumor growth, overexpression of chinmo with Ras<sup>V12</sup> or activated Notch is sufficient to promote tumor growth in eye-antennal discs (Doggett et al., 2015). Chn encodes a zinc finger transcription factor that cooperates with scrib<sup>-/-</sup> to promote tumor growth (Turkel et al., 2013). Although we found that knockdown of these genes did not activate <italic>JNK</italic> signaling, it is possible that these putative target genes also contribute to the miR-306/miR-79-induced tumor suppression and thus Ras-Dlg+miR-306/79+dRNF146 clones are smaller than Ras-Dlg clones..</p><disp-quote content-type="editor-comment"><p>After that, the authors state: &quot;Together, these data indicate that miR-306 and miR-79 directly target dRNF146 mRNA, thereby enhancing JNK signaling activity and thus exerting the tumor-suppressive effects.&quot; The authors make different correlations to reach that conclusion but do not show evidence proving that dRNF146 depletion is in fact enhancing JNK activity in those tumors. To conclude that, the authors should prove that JNK activity levels are upregulated when dRNF146 is downregulated in those tumors.</p></disp-quote><p>We agree with the comment. As responded in the Essential Revisions #11, we have now tested whether <italic>JNK</italic> activity levels are upregulated when dRNF146 is downregulated in Ras-Dlg tumors using the pJNK antibody. As shown in the revised Figure 5—figure supplement 5, knocking down RNF146 indeed enhanced <italic>JNK</italic> activity in Ras-Dlg tumors.</p><disp-quote content-type="editor-comment"><p>To demonstrate their model, the authors should show that Tnks overexpression alone does not affect normal growth in otherwise wild type clones. The authors should also show that miR-309/79 modulation affect Tnks protein levels.</p></disp-quote><p>We sincerely thank the reviewer for the comment. As responded in the Essential Revisions #12 and #13, we have now tested whether Tnks overexpression alone affect normal growth. As shown in Figure 6G-H, Tnks overexpression alone resulted in smaller clone size compared to control. However, considering that overexpression of Tnks alone shows larger clone size than Ras<sup>V12</sup>/dlg<sup>-/-</sup>+Tnks (Figure 6H and J, quantified in Figure 6K), we believe that Tnks suppresses growth of Ras<sup>V12</sup>/dlg<sup>-/-</sup> tumors by cooperating with <italic>JNK</italic> signaling. We also detected the Tnks protein levels when miR-306 or 79 is overexpressed. As shown in Figure 6—figure supplement 1, overexpression of miR-306 or 79 significantly upregulated Tnks protein level.</p></body></sub-article></article>